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ABSTRACT OF THE DISSERTATION
HPV VACCINATION INTENTIONS IN BLACK YOUNG ADULTS
by
Kayla N. Mathis-Gamble
Florida International University, 2020
Miami, Florida
Professor Sandra Gracia-Jones, Major Professor
Purpose: The purpose of this quantitative study is to assess perceived: vulnerability,
severity, benefits, barriers; and risk behavior factors (trust/mistrust, social influence, and
prior sexual behavior) regarding intent to initiate and complete the HPV vaccination
series, in HPV vaccine naïve, Black college students aged 18-24, enrolled in a minority
serving institution (MSI) and/or historically black college/university (HBCU).
Methodology: After IRB approval was obtained, 158 Black college students were
recruited from the MSI/HBCU(s). The study was guided by the Health Belief Model.
The participants completed paper and pencil surveys.
Findings: While male gender influenced the intent to be vaccinated in Black college
students, age and location did not influence vaccination intent. There was no significant
interaction between perceived: vulnerability and benefits and gender in reference to
participants’ intent to receive the HPV vaccination; yet perceived severity and barriers
negatively influenced plan to receive vaccination. Finally, female participants were less
likely to plan to receive the vaccination than males; if they perceived more vulnerability
and benefits of HPV vaccination. There was no significant interaction between
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trust/mistrust, social influence, or prior sexual behavior; although for trust/mistrust and
prior sexual behavior had statistical significance, (p=0.033 and p= 0.032) respectively;
female participants were less likely to plan to receive the vaccination than males. There
was a statistical difference noted regarding the change in dosing of HPV vaccines from
three to two doses, Black college students were more likely to intend to become
vaccinated (p=0.006).
Conclusion: As depicted in the framework, gender, perceived severity and perceived
barriers were predictive of intentions to vaccinate for HPV. However, age, location of
college, trust/mistrust, social influence, and prior sexual behavior were not found to have
relative contributions to intentions of Black college students to receive the HPV
vaccination. Also, it was found that the change in dosing, that is reducing the number of
shots in the required HPV series, contributed positively to Black college students
receiving the HPV vaccine. The results of this study only provided minimal support for
the Health Belief Model as a theoretical framework which could effectively explain the
behaviors of Black college students’ intention to be vaccinated for HPV.
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HPV Vaccination Intentions in Black Young Adults: Chapter 1
Introduction
Genital Human Papilloma virus (HPV) is a sexually transmitted infection (STI)
that has been linked to cancer in women and men. HPV- associated cervical cancers
affect Black women more than other women (Centers for Disease Control and Prevention
[CDC], 2019a). The incidence of HPV-related cancers can be eradicated by over 90%,
with the proper utilization of the HPV vaccination (CDC, 2018c). Research has shown
that parents in the United States have concerns regarding vaccinations in general and may
be hesitant regarding the HPV vaccine (Thomas, Caldera, & Maurer, 2019). Therefore,
many young men and women entering college have not received the HPV vaccination.
College students can receive health care, such as vaccinations, without the necessity of
parental consent. However, studies have shown that college students may not even be
aware that there is an HPV vaccine, and that they should get vaccinated. The purpose of
this study was to identify the variables that specifically influence Black college students’
intentions to vaccinate, in order to help guide interventions aimed at increasing HPV
vaccination rates among this high-risk group.
HPV is a virus with over 100 strands (D’Urso, Thompson-Robinson, & Chandler,
2007). The virus can lead to genital warts or anogenital cancers, involving the vulva,
vagina, and cervix of females, the penis of males, and the anus and rectum of both
genders (CDC, 2015a).
The World Health Organization (WHO) (2016) reports that there are 290 million
women globally who have been infected with HPV. HPV can be the precursor to several
types of cancer. Cancers caused by HPV have a disparity as well, with cervical cancer
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being highest, followed by anal, vaginal, oropharynx, vulvar, and penile cancer (CDC,
2016d). In the United States (U.S.), HPV is responsible for 34,800 cancer diagnoses
annually (approximately 24,886 cases in women and 19,113 cases in men) (CDC, 2019a).
In 2013, the estimated deaths for cervical cancer in African American women was 720
deaths (American Cancer Society, 2013). To eradicate this epidemic, in 2006 a primary
prevention strategy, a 3-dose HPV vaccination series, debuted in the U. S. However,
because HPV is a STI, promotion of the vaccine is fraught with negative undertones due
to cultural expectations, religious/spiritual beliefs, parental beliefs and perceptions, and
regional/societal norms (Thomas, Blumling, & Delaney, 2015). HPV impacts individuals,
families, communities, and the health care system. The significance of these facts serves
as the impetus for this research looking at the problem HPV has caused in the US, in
Black young adults.
Vaccine Debut
The CDC has indicated that six million more Americans become infected with
HPV each year (CDC, 2012a). One way to prevent STIs is through the primary
prevention strategy of vaccination. The HPV vaccine series is currently recommended for
females (age 9-26) and males (age 11-26). Vaccination recommendations for HPV
remain controversial because of parental concerns, the intimate nature of the spread of the
disease, knowledge and awareness of the disease, and health care barriers (Thomas,
2008).
In the United States, there is a board that is comprised of medical and public health
experts that makes recommendation for vaccine utilization called the Advisory Committee
on Immunization Practices (ACIP). Although, the ACIP has recommended the utilization
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of the HPV vaccine, college age individuals have demonstrated a low uptake of the vaccine
(CDC, 2007).
While vaccination is a solution to preventing HPV, other primary prevention
strategies are necessary, including knowledge and awareness of HPV prevention and
transmission. Researchers have studied and documented that there has been an increase in
awareness of HPV and HPV vaccine among college-aged women since the debut of the
vaccine in 2006 (Jain et al., 2009; Allen et al., 2009, & Caron, Kispert, & McGrath, 2008);
however, vaccine uptake has been low (Ratanasiripong, 2012).
Initially, the HPV vaccine series required 3 doses of the vaccine to complete the
vaccine series. Individuals between the ages of 13-17 have only had small growths in
vaccine coverage, (males 41.7% and females 60%) in 2014 (CDC, 2015b). Cook et al.
(2010) noted that Blacks were 44% less likely than Whites to complete the vaccination
series. Males are less likely than females to receive the HPV vaccination (Thomas,
Strickland, & Higgins, 2017). Although the HPV vaccine has been added to the
recommended vaccine series, geographical locations, legislation, cost, and practicalities
of a multiple-dose vaccine series must be considered before a true national adherence to
the recommendation will be successfully implemented (CDC, 2007; Outterson, 2009,;
United States Census Bureau (USCB), 2012,; & Abiola, Colgrove, & Mello, 2013).
In October 2016, the ACIP voted to recommend that adolescents aged 11-12,
receive only 2 doses of the vaccine, compared with the previous recommendation of 3
doses (CDC, 2016a). To date, no research has been published that looks at the intentions
of Black vaccine naïve college students to vaccinate now that the series has been changed
from 3 doses to 2 doses for young adolescents.
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Gender and Racial Disparities
HPV infection causes cancer in more women than men, but gay and bisexual men
are also at high risk for some HPV-related health problems (CDC, 2012b). Gender
disparity is evident, since about 21,300 females and about 12,100 males have HPV
associated cancers (CDC, 2012a). Ratanasiripong (2012) noted that the 18 million U. S.
college and university students represent a large portion of the American population that
are at risk for developing HPV infection.
In comparison with their White counter parts, Black women had higher rates of
HPV-associated vaginal cancer, but lower rates of vulvar and oropharyngeal cancer
(CDC, 2019b). When compared with their White counterparts’ Black men have higher
rates of anal and rectal, but lower rates of penile and oropharyngeal cancer (CDC,
2019b). Black women also have a higher rate of deaths related to cervical cancer (CDC,
2016c). The impact of this disease affects individuals, families, and communities.
Geographic Location
In the world, cervical cancer ranks as the 3rd most frequent cancer among
women. In a comparison between the Americas, Africa, Asia, Europe, and Oceania, the
Americas ranked second in cervical cancer rates (Bruni et al., 2014). In 2013, it was
estimated that there are nearly 42 million African Americans living in the US, and that
they do not equally reside throughout the US (USCB, 2012). This is particularly
important to note since residential distribution for African Americans is concentrated in
New York, California, and the South, with one out of every four African Americans
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residing in New York, Florida, or Texas (USCB, 2010). There may be differences in
HPV vaccination challenges or barriers for rural versus urban populations (Thomas,
Strickland, Di Clemente, Higgins, & Haber, 2012).
Trust/mistrust
Trust can be an underlying factor when an individual is determining their health
care regimen, and this includes acceptance or denial of vaccines. This trust issue may be
a result of unethical medical experiments conducted in the Black American population.
Examples would include the unethical experiments conducted on Black males in the
Tuskegee study, or the experimentation on the cancer cells from a Black American
woman, without informed consent. While older Black Americans may remember the
Tuskegee syphilis experiments, Black American adolescents and young adults may not.
Brandon, Isaac, and LaVeist (2005) conducted a study to differentiate between mistrust
of medical systems and the medical studies conducted in Tuskegee, Alabama. The
researchers found that race played a significant difference in individuals mistrust in
medical care, although there was no difference in knowledge about the study by race
(Brandon, Isaac, and La Veist, 2005). However, the data revealed that double the number
of Black individuals in the study believed that the Tuskegee study participants were
purposely infected with syphilis (Brandon, Isaac, and La Veist, 2005). Additionally, the
Black participants believed that a similar study could occur in 2018.
Since the inclusion of the HPV vaccine series in the recommended vaccine
schedule, several changes have occurred. This includes changes in the gender of
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recipients, changes in the number of viruses the vaccine produces immunity too, and
changes in the number of vaccination doses. These changes may further fuel the feelings
of mistrust of the efficacy of the vaccine and the knowledge of health care providers.
LaVeist, Isaac, and Williams (2009) conducted a study to determine if a
relationship existed between mistrust and health care service utilization. The authors
found that medical mistrust resulted in a delay to seek medical care, nonadherence, and
failure to keep appointments (LaVeist, Isaac, & Williams, 2009). Carpenter et al. (2009)
found that, in comparison to their Caucasian counterparts, African American males
exhibited a higher distrust in physicians. HPV vaccine acceptance can be influenced by
indirect and direct individual experiences (Nan, Zhao, & Briones, 2014). This must be
taken into consideration when planning and implementing strategies to increase
vaccination in this vulnerable population. Scarinci, Garces-Palacio, & Patridge (2007)
noted that African American females were skeptical regarding the HPV vaccine.
Social influence
Individuals are influenced by varying stimuli; this also remains pertinent in the
seeking of health care. Numerous studies have recognized the correlation between HPV
vaccine uptake and health care provider recommendations (Dorell, Yankey, & Strasser,
2011; Kester et al., 2013). However, the social influences on HPV vaccine uptake have
not been well represented in the literature. Rambout, Tashkandi, Hopkins, & Tricco
(2014) noted that social norms facilitated HPV vaccination uptake. The proposed study
will enhance the literature regarding social influence and HPV vaccine uptake in Black
male and female college students.
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Previous sexual encounters
The introduction of the HPV vaccine created feelings of concern regarding an
increase in sexual initiation and/or in increase in promiscuity (Constatine & Jerman,
2007; Hopkins & Wood, 2013). Bednarczyk, Davis, Ault, Orensteinn, & Omer (2012)
found that there was not an increased rate in sexual activity-related outcomes, after HPV
vaccinations of 11-12-year olds. Another study found that HPV vaccination did not have
an association with being sexually active or with the number of sex partners (Liddon,
Leichliter, & Markowitz, 2012). This is promising data, but this study will determine if
this remains true in the Black male and female college students.
Change in dosing
Research has been conducted to determine adherence to the three dose HPV
vaccine regimen (Widdice, Bernstien, Leonar, Marsolo, & Kahn, 2011). The researchers
found that in Black participants the rates for HPV vaccine adherence to schedules and
vaccine completion were low (Widdice, Bernstien, Leonar, Marsolo, & Kahn, 2011).
Little is known about the new recommendations’ effects on Black male and female
college students’ intention to vaccinate now that the dosing has changed for young
adolescents from 3 doses to 2 doses.
Conclusion
One would hypothesize that over the past twelve years the rates of HPV
vaccination adherence would have a significant improvement. Although rates are
increasing, overall adherence has not reached 50%. The percent of up to date (UTD) HPV
vaccine status in adolescents for 2016 was only 43.4 (N=20475) (Walker et al., 2016).
Completion rates for ≥ 3 doses (the previous standard for the vaccine series) for all
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adolescents was 37.1% (N=20475) in 2016, up from 34.9% (N=21875) in 2015 (Walker
et al., 2016). A review of the literature regarding HPV vaccination, Black college
students, gender differences, geographic location, perceived vulnerability, perceived
severity, perceived benefits, perceived barriers, trust/distrust, social influence, or prior
sexual behavior, has found that these variables may affect intent to vaccinate, but further
studies are needed to describe the effect of these variables on college-age Black students’
and their intent to receive the HPV vaccination series.
Statement of the Problem
Although a 3-dose HPV vaccine series has been available since 2006, rates for
completion of the series remain low in the U. S. Research studies conducted with HPV
vaccination found that lack of knowledge about HPV, parental and physician discomfort
with vaccinating teenagers against STIs, vaccine cost and financing issues, adolescents’
health –seeking behaviors, and concerns about vaccines in general, influenced intent to
receive the vaccination series (Dempsey & Davis, 2006; Zimet, 2006). Giuliana et al.
(2008) noted that male sexual habits affect the rates of HPV infection in female partners,
thus a greater understanding of HPV infection in men is an essential component of
cervical cancer prevention in women. HPV vaccination rates remain low in the U. S.
Although some surveillance data has been published for females, male uptake published
data is limited; consequently, monitoring of vaccine uptake in racial and ethnically
diverse male and female populations are warranted. Despite the available research on
college student’s intentions to vaccinate, relatively little is known about impact or effect
of variables such as gender differences, geographic location, perceived vulnerability,
perceived severity, perceived benefits, perceived barriers, trust/distrust, social influence,
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or prior sexual behavior of Black college students aged 18-24, on intent to
vaccinate. Consequently, understanding and addressing the variables that specifically
influence Black college students’ intentions to vaccinate can guide interventions aimed at
increasing HPV vaccination rates among this high-risk group. The CDC has recently
recommended changing from a 3-dose to a 2-dose HPV vaccine series for young girls,
but no studies have yet explored the impact of this practice change on young adults’
intent to receive the HPV vaccination series.
Theoretical Framework
Several theories have been utilized in regard to HPV vaccination. The Health
Belief Model will guide this study. This model explains individuals’ behaviors based on
their personal beliefs or perceptions about disease process and the strategies to detour the
diseases occurrences (Chambers & Paraska, 2014). This theory was originally composed
of four constructs, (perceived: seriousness, susceptibility, benefits, and barriers), but has
evolved to include cues to action, motivating variables, and self-efficacy (Chambers &
Paraska, 2014). This model also suggest that an individual’s preventative health
behaviors are dependent on perceived susceptibility to disease, the severity of health
outcomes, the benefits of and barrier to behavior engagement, and cues to motivate
(Rosenstock, 1974). Perceived seriousness refers to an individual’s belief of the severity
of a disease, this can be influenced by difficulties the disease would create or the effects
of it on the person’s life (Chambers & Paraska, 2014). Perceived susceptibility or
personal risk looks at how an individual will see/perceive the danger that is involved in a
health behavior (Chambers & Paraska, 2014). The constructs of perceived seriousness
and perceived susceptibility are combined to determine the individual’s perceived threat
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(Stretcher & Rosenstock, 1997). The threat must cause the individual to feel they are at a
real risk of acquiring a serious illness for behavior to change (Chambers & Paraska,
2014) Perceived benefits are rooted in a person’s opinion of the worth of a new behavior
in decreasing the risk of disease development (Chambers & Paraska, 2014). Thus, new
behavior is dependent upon the individual believing that they will decrease their chance
of developing disease (Chambers & Paraska, 2014). Finally, perceived barriers are based
on the individual’s evaluation of the roadblocks to developing a new behavior (Chambers
& Paraska, 2014). New behavior will only be implemented if a person believes that the
benefits of the new behavior outweigh the results of the prior behavior (Chambers &
Paraska, 2014).
Although this model began with four constructs, they are altered by modifying
variables (Chambers & Paraska, 2014). These variables are multi-faceted and vary by
individual, examples include but are not limited to: culture, education level, past
experiences, skill, and motivation (Chambers & Paraska, 2014). Cues to action are
another part of this theory; they are events, people, or things that influence people to
modify their behavior (Chambers & Paraska, 2014). Lastly self-efficacy is a driving force
in the HBM theory (Rosentock, Strecher, & Becker, 1988). Self-efficacy, as described by
Bandura, deals with one’s belief that they can achieve something (Bandura, 1977).
Overall this model deals with individual perceptions, modifying factors, and the
likelihood of action (Chambers & Paraska, 2014). Figure 1 addresses the theory as
suggested by the HBM.
The HBM has been used for research with HPV in college students (Hsu et al.,
2009; Painter et al., 2008, Bynum et al., 2011; & Thomas et al., 2016). Vaccination rates
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for HPV have increased in studies where the HBM was utilized (Hawe et al., 1998 &
Larson et al., 1982). Fazekas, Brewer, and Smith (2008) noted that within the context of
HPV vaccination, perceived likelihood is rooted in the belief that HPV infection and
cervical cancer are likely outcomes. Believing that HPV infection is related to cervical
cancer would have serious negative health effects is perceived severity (Fazekas, Brewer,
& Smith, 2008). The belief that HPV vaccine will reduce the risk of HPV infection and
cervical cancer, is perceived benefit/vaccine effectiveness (Fazekas, Brewer, & Smith,
2008). Vaccine cost could be a perceived barrier, and situational and social factors are
cues to action (Fazekas, Brewer, & Smith, 2008).
For this study the theoretical framework, based on the Health Belief Model, is
illustrated in figure 2.
Theoretical Assumptions
Chambers and Paraska (2014) noted that the theoretical assumptions for the HBM
are as follows: an individual has the desire to avoid illness; an individual has the desire to
get well; and that an individual has a belief that a specific health action by that person
would prevent illness.
This study is guided by theoretical and research assumptions. The HBM also guides the
theoretical assumptions for this study. The theoretical assumptions are:
1.

Black college students ages 18-21 will be motivated to receive the HPV

vaccination by their individual perceptions and modifying behaviors.
2.

Belief that HPV can cause cancer, and that HPV vaccination can prevent

cancer, will affect an individual’s desire to receive the vaccine (perceived
susceptibly and perceived severity).
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3.

Demographic variables are modifiable and serve as determining the

likelihood of taking the recommended preventative behavior, in this case HPV
vaccination.
Specific Aims of the Study
The purpose of this quantitative study in HPV vaccine naïve, Black college
students aged 18-24, enrolled in a historically black college/university (HBCU) and/or a
minority serving institution (MSI), was to assess perceived vulnerability, perceived
severity, perceived benefits, perceived barriers, and risk behavior factors (trust/mistrust,
social influence, and prior sexual behavior) regarding intent to initiate and complete the
HPV vaccination series.
Research Questions/Hypotheses
Questions
The study addressed the following research questions:
1. Is there a difference in demographics (age, gender, geographic location) between
Black college students who intend to receive the HPV vaccine and those who do
not intend to receive the vaccination?
2. What are the relative contributions of perceived vulnerability, perceived severity,
perceived benefits, and perceived barriers to HPV vaccination intention among
male and female Black college students?
3. What are the relative contributions of trust/mistrust, social influence, and prior
sexual behavior to HPV vaccination intention among male and female Black
college students?
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4. Has the new practice recommendation to change the HPV vaccination series from
a 3-dose to a 2-dose series for young girls caused a difference in intent to vaccinate
for college students, and is there a difference between male and female Black
college students?
Hypotheses
1. There is a difference in demographics (age, gender, geographic location) in Black
college students who intend to vaccinate and those that do not.
2. Higher perceived vulnerability, perceived severity and perceived benefits scores,
and lower perceived barriers scores will be associated with increased intentions to
receive vaccination in Black college students who intend to vaccinate.
3. Trust, social influence, and prior sexual behavior will have a positive effect on
intent of Black college students to receive the HPV vaccination.
4. The decrease in the vaccine series dosing from 3 doses to 2 doses will have a
negative effect on Black college student’s intentions to vaccinate. Gender will play
a role in the decision to vaccinate based on the change in HPV Vaccination policy
for the number of doses for young adolescents.
Definition of Terms and Operationalization
TERM

Conceptual Definition

Operational

“What it means”

Definition
“How

to

measure”
Black

From African descent, having dark colored Self-identified
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skin

as

Black

or

deriving from
African
descent,
including
African
American,
African
Caribbean,
etcetera
College

Current enrollment in a HBCU or a MSI

Student

Proof

of

current student
ID, and on the
enrollment list
provided
the

by

school

registrar. Can
be full or part
time status
Young adults

An individual in the early stage of adult hood Individuals
self-identified
as ages 18-24
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Gender

Being male or female

Self-identified
as male,
female,
transgender
male, or
transgender
female

Past

sexual Behaviors performed by the individual or The results of

behavior

received by the individual related to sexual the
acts:

vaginal, anal,

oral,

answers

masturbation, from

foreplay

the

Sexual

Risk

Survey (SRS)
Instrument and
the

Sexual

Experience
Questionnaire
Social

Individuals or groups that influence behavior

Influence

Results

from

answers from
the Perceived
Social
Influence
Health
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on

Behavior
Instrument
(PSI-HB)
Trust/distrust Believing in something or not believing in Measured
something

by

the

Health

Care

System

Distrust Scale
(HCSDS)
Perceived

What an individual think about their risk of Measured from

vulnerability

something

the

SHPVS

Instrument
questions # 59, 11, & 25
Perceived

How serious something an individual think Measured from

severity

something is

the

SHPVS

Instrument
questions # 10,
12, 13, 15, 16,
& 21
Perceived

What an individual think are the positive Measured from

benefits

aspects of something

the

SHPVS

Instrument
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questions # 14, 14, & 17-20,
Perceived

What an individual think is stopping them

barriers

Measured from
the

SHPVS

Instrument
questions # 2224, 26, & 27
Vaccine

Have not received any dose of HPV vaccine

Naïve

Self-reported
denial of HPV
vaccine
immunization

Intention

What an individual plan to do

Measured from
the

SHPVS

entire
Instrument
score

and

measured
the

in

added

question to the
Instrument
Rural

“Rural” encompasses all population, housing, Attending
and territory not included within an urban school
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in

area.

Tuskegee,

From:

Alabama

https://www.census.gov/geo/reference/urbanrural.html
Urban

The Census Bureau identifies two types of

Attending

urban areas:

school

•

Urbanized Areas (UAs) of 50,000

in

Miami, Florida

or more people;
•

Urban Clusters (UCs) of at least

2,500 and less than 50,000 people.

https://www.census.gov/geo/reference/urbanrural.html

Significance of the Proposed Study
Research that explores the relationship between HPV awareness and vaccine uptake
related to ethnicity, knowledge, social influence, and prior sexual behavior, in diverse
young adults from various geographic regions, is needed to further expand the body of
knowledge for HPV vaccination. In addition to this, research that explores whether the new
policy on decreasing HPV dosage from 3 shots to 2 shots in young adolescents will affect
individuals’ intentions to vaccinate. This increase in understanding will help to better
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inform the development of more effective public health interventions programs. These
programs can target and eliminate racial, gender, and geographic health disparities in HPV
treatment and care.
Assumptions of the Study
The research assumptions are:
1.

The participants in this study can read and understand English.

2.

Participants will provide honest answers to the questionnaires.

3.

The instruments chosen will measure the respective variables.

4.

The Health Belief Model is appropriate to answer the research questions in
this study.

5.

Analysis of the data results will aid in interpreting the data correctly for the
specified population and the results will further knowledge and
understanding.
Summary

HPV virus can lead to cancer. These cancers effect men and women but is
disproportionately dispersed among young Black Americans. This study helps to fill gaps
in the current state of science. This research looked at gender, racial, and geographic
disparities in HPV infection. This study also assessed the impact of perceived
vulnerability, perceived severity, perceived benefits, perceived barriers, and
(trust/mistrust, social influence, and prior sexual behavior) on intent to initiate and
complete the HPV vaccination series.
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Figure 1.

(Glanz et al., 2002)
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Figure 2.
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Chapter 2: Review of the Literature
Introduction
The incidence of human papilloma virus (HPV) related cancers can be eradicated
by over 90%, with the proper utilization of the HPV vaccination (CDC, 2018c). It is
estimated that 79 million individuals are infected with human papilloma virus (HPV),
while 14 million more Americans become infected each year (CDC, 2017b). The
population most effected by the HPV virus are individuals in their late teens and early
20s (CDC, 2017b). HPV is yearly responsible for 33,700 new HPV related cancers
diagnosis (CDC, 2018f). In the United States, 19,400 women and 12,100 men are
diagnosed with cancers that are caused by HPV (CDC, 2017b). Although these statistics
are devastating, decreasing these disturbing statistics by utilization of the HPV vaccine is
a difficult task due to: adherence to vaccination recommendations, the intimate nature of
the spread of the disease, knowledge and awareness of the disease, and health care
barriers (Thomas, Strickland, Diclemente & Higgins, 2013; White, 2014). The HPV
vaccination could prevent 32,000 cancer diagnosis (CDC, 2019d). While primary
prevention strategies have been the norm for early diagnosis of cervical cancer, each year
HPV causes 10,800 new cases of cervical cancer in the United States (CDC, 2018c).
Thomas (2008) noted that HPV vaccination would be beneficial to prevent cervical
cancer, promote sexual health education, promote reproductive health education, and
begin the discussion regarding sexually transmitted infections.
Although the HPV vaccine has been included in the vaccination schedule in the
United States since 2006, HPV is a sexually transmitted infection (STI), thus
implementation of the vaccine comes with negative undertones for many cultural beliefs,
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religious factions, and societal norms. Thus, HPV remains the most prevalent (STI) in
males and females in the United States. Jones and Cook (2008) noted that, HPV vaccine
could have vast benefits for men and women by decreasing morbidity and mortality
associated with cervical, anal, and penile cancers. Jones and Cook (2008) also noted that
these benefits to public health can translate into a decrease in economic and emotional
costs associated with genital infection. However, if providers are not aware of the current
pros and cons of the vaccination administration, they cannot advocate successfully for
their clients (Thomas, 2008). White (2014) noted that the overall benefits of vaccination
make it paramount that the fight continues to increase immunization rates. If vaccine
administration is done along with Papanicolaou smears, female patients will have a better
chance of preventing cervical cancer (White, 2014). The healthcare community should
utilize a multidisciplinary approach to encouraging HPV vaccination, this would include
involving primary care providers and specialist alike (White, 2014).
State of the Science
The Centers for Disease Control and Prevention (CDC) has indicated that
fourteen million more Americans become infected with HPV each year (CDC, 2017b).
Although these statistics are devastating, the implementation of this vaccine has been
difficult; especially since it means admitting that children are at high risk for exposure to
a STI. HPV vaccine initiation and dosage completion are pertinent to help prevent HPV
related cancers (Thomas, 2016).
Jones and Cook (2008) noted that vaccinations are one of the most successful
public health strategies to preventing and controlling infectious disease. The HPV
vaccine is currently recommended for females (ages 9-26) and males (ages 9-26). The
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CDC recommends that boys and girls that did not receive the vaccine while they were
young, receive catch up vaccinations (boys up until age 21, and girls up until age 26
(CDC, 2017c). It is also recommended that gay men, bisexual men, and mean and women
with compromised immune systems that did not receive the vaccine while they were
younger, receive catch up vaccination through age 26 (CDC, 2017c). In 2018, the HPV
vaccine received approved for men and women 27-45 years old (U.S. Department of
Health and Human Services (USDHHS), 2018a). Even if exposure to HPV has occurred
through sexual contact, the vaccination is still recommended (CDC, 2017c). Since
cervical cancer results from persistent and reoccurring exposure to high risk strands of
HPV infection, the benefit of protective immunity can still be achieved with vaccination.
Since 2006, there has been an approved vaccination to protect girls and women
against four strands of HPV, 6, 11, 16, and 18 (FDA, 2103). This quadrivalent therapy
has demonstrated safety and nearly 100% efficacy in preventing HPV 16, 18, 6, and 11
(FDA, 2014). Researchers have studied and documented that there has been an increase
in awareness of HPV and HPV vaccine among college-aged women since the debut of
the vaccine in 2006 (Jain et al., 2009; Allen et al., 2009, & Caron, Kispert, & McGrath,
2008); however, vaccine uptake has been low (Ratanasiripong, 2012). CDC (2010)
reported that among adolescents aged 13-17, 44.3% reported receiving at least 1 dose and
26.7% reported receiving 3 doses of the vaccine. However, the CDC (2018c) noted that
among girls and boys aged 13-17, 65% and 56% reported receiving at least 1 dose of the
vaccine.
In October 2009, a bivalent vaccine was approved to provide protection against
strands 16 and 18 (Dunne et al., 2011). This vaccine was for girls and women aged 10 to
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25 (Ratanasiripong, 2012). In 2009, a bivalent vaccine was approved to prevent strands 6
and 11 in boys and men ages (9-26). The administration of the vaccination series is in
three injections, over a six-month period. Although the vaccine series was accepted and
added to the recommended vaccine series in ages 9-26 for males and females, it has
proved a daunting task to increase vaccination implementation in the high-risk vulnerable
populations.
In February 2015, the 9-valent HPV vaccine was approved for routine vaccination
(CDC, 2015b). It will protect against HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58. The
vaccine is recommended for females aged 9-26 and males aged 9-15. This vaccine will
again be a catalyst in preventing HPV infection. However, if the vaccine is under
prescribed, administered, and utilized like its predecessors, it will not prove beneficial to
society.
In October 2016, yet another change occurred, 2 doses of the vaccine were found
to have the same efficacy as 3 doses. The vaccine would need to have been administered
young adolescents prior to age 15; the individuals must have received the two doses 6-12
months apart to be eligible to complete the 2-dose vaccine regimen (Meites, Kempe, &
Markowitz, 2017). In October 2018, the Gardasil 9 vaccine has been approved for men
and women 27-45 years old (U.S. Department of Health and Human Services, 2018a)
HPV and College Students
Although the Advisory Committee on Immunization Practices (ACIP)
recommended the utilization of the HPV vaccine, college age individuals have
demonstrated a less than optimal uptake of the vaccine (Barnard et al., 2017). In studies
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conducted by Jain et al. (2009) and Caskey, Lindau, and Alexander (2009), between 9-10%
of women aged 18-26 years had initiated the HPV vaccine schedule.
Ratanasiripong (2012) noted that the 18 million United States (US) college and
university students represent a large portion of the American population that are at risk
for developing HPV infection. Patridge et al. (2007) noted that HPV infection is most
prevalent among traditional college-aged young adults. Habel et al. (2018) noted that 73
% (n=885) of the colleges surveyed offered STI diagnosis and treatment on campus for
students. In a study conducted by Cavazos-Rehg et al. (2009), it was noted that there was
a 10% likelihood that teenage girls’ sexual debut would take place by age 14 (2009). This
increases their risk for exposure to HPV infection. The development of HPV is
multifaceted and included risk factors such as, < 25 years old, first sexual intercourse at
an early age, failure to utilize condoms, multiple sex partners, and having partners who
have multiple sex partners or have a history of HPV (Ratanasiripong, 2012). Since many
college and university age students are living away from home and not supervised by
adults the stage is set for engagement in unprotected high-risk sexual behaviors
(Ratanasiripong, 2012). It should also be noted that individuals’ ages 18-25 years old
were not likely to get treatment for STDs, as they feared their anonymity would not be
maintained (Leichliter, Copen, and Dittus, 2017). The American College Health
Association (ACHA) (2018), reported that only 57% of college students that participated
in the survey confirmed receiving the HPV vaccine.
HPV Defined
HPV is a virus. HPV infection involves the skin and replicates in epithelial cells,
after the virus is introduced to a host in over 100 strands of the virus (D’Urso,
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Thompson-Robinson, & Chandler, 2007). Since there are hundreds of strands of HPV
that have been identified, it is important to note that all types are not highly contagious
(CDC, 1999). The virus can be spread via oral, anal, or vaginal skin to skin contact if
contacted is made with an individual that has an active outbreak (CDC, 1999). The virus
can also be spread by oral, anal, or vaginal intercourse. Bruni et al. (2017) noted that the
primary route of transmission of genital HPV infection is sexual intercourse. The virus
can lead to genital warts or anogenital cancers, involving the vulva, vagina, and cervix of
females, the penis of males, and the anus and rectum of both genders (CDC, 2015a). HPV
is also linked to causing cancers at the base of tongue and tonsils (CDC, 2019c). While
HPV infection is benign and does not cause health problems in most cases, it can have
lethal and potentially serious consequences in others. Bendik, Mayo, and Parker (2011)
noted that a strong link can be found between genital HPV and cervical cancer.
Strands
The most common cancer-causing strands of HPV are HPV-16 and 18 (Bendik et
al., 2011). While the most two common causes of genital warts are HPV-6 and 11
(Bendik et al., 2011). 70% of cervical cancers are caused HPV 16 and 18, and 90% of
genital warts infections are caused by HPV 6 and 11 (Bendik et al., 2011). So how can
this virus be prevented and eradicated? Like any viral infection, it cannot be cured.
Although latex condoms have proven to be a useful instrument in preventing other viral
sexually transmitted infections, they are not as effective against the transmission of HPV
since all the infected skin may not be covered by a condom (CDC, 2015a).
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Transmission/Signs and Symptoms/Detection
The true incidence of HPV infection can be difficult to assess, since the infections
clear quickly and infected/exposed individuals may not know they are at risk for infection
(Dunne et al., 2007). It is also difficult to diagnose HPV since most people are
asymptomatic, and infection is usually cleared or undetectable in the majority of exposed
individuals (CDC, 2015a). According to (Association of Reproductive Health
Professionals, 2013) detection of HPV is done by looking for precancerous cervical
lesions via Pap examination; if high grade precursors of cancer are detected, they are
treated. Although this method has proven successful, it has several limitations, anxiety,
physical discomfort for the patients, and poor Pap test screening by some ethnic
minorities (Adams, Jasani, & Fiander, 2007).
Vaccination with HPV
A study conducted by Jones and Cook (2008), with 340 male and female
university students, found several factors associated with the participants’ intention to
vaccinate. The factors included: ever having been diagnosed with a sexually transmitted
infection (STI), having a close friend or relative with HPV, having had more than five
sexual partners, greater perceived risk for HPV infection, availability of a free vaccine,
and vaccine recommendation from a physician, spouse, partner, or friend. The authors
also found there were factors that decreased the participant’s intentions to vaccinate; this
included age, race, recruitment setting, ever having genital warts, or perceived severity of
HPV, and paying $50.00 for the vaccine (Jones & Cook, 2008). The participants in the
Jones and Cook study (2008), were male (138) and female (202), mostly white (82.6%)
with ages ranging from 18-32 years old that were recruited from the student health center
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(Jones & Cook, 2008). The authors also found that males were more likely to intend to
become vaccinated if it was communicated to them that the vaccine prevented genital
warts as well as cervical cancer, thus wording in recruitment campaigns should be
considered.
Patel et al. (2012) conducted a study with 256 female students at a university
health clinic. The authors randomly performed an educational intervention or provided
standard care for the participants and then they examined the vaccine intent and uptake
results. Patel and colleagues found that at baseline 41% of the participants intended to
receive the HPV vaccination; than those who had perceived parental approval/perceived
vulnerability/and belief in the health benefits of HPV had an increased intent to vaccinate
(Patel et al., 2012). While sexual activity and lack of supplemental health insurance
lowered the intent to vaccinate (Patel et al., 2012). After this, they noted that HPV
vaccine only 5.5% and did not differ by group; and that initial baseline intent
significantly affected HPV vaccine uptake (Patel et al., 2012). The majority of the
participants in this study were Caucasian, with ages from 18-26 years old. The
individuals who wanted the vaccine cited the following reasons: worry about developing
cervical cancer or genital warts, health care provider recommendations; while the most
common reasons cited for not wanting the vaccine were: safety concerns, side effects,
high out of pocket costs or insurance copayments, long-term consequences, and not being
at risk for STI or genital warts.
Bendik, Mayo, and Parker (2011) conducted a study with 1,975 female
undergraduate student ages 18-23 at a southeastern university, most of the participants
(90%) were white. Participant that were more likely to receive the vaccine had parental
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approval, partner approval, friend approval, and were white (Bendik, Mayo, & Parker,
2011). Bendik, Mayo, and Parker (2011) also noted that those who had already received
the vaccine were as follows: they had perceived importance of HPV, perceived severity
of cervical cancer, perceived likelihood of acquiring cervical cancer; other associated
factors were age of sexual debut, number of partners, age, and HPV-related knowledge
(Bendik, Mayo, & Parker, 2011).
Manhart et al. (2011) conducted a longitudinal study with 428 women, 22 years
old in a suburban metropolitan area in Seattle, Washington. The participants were
recruited from 10 public schools from 1993-2009. Manhart and colleagues (2011) noted
that vaccine initiation was more common younger women in the cohort, attendance in
school, utilization of a condom during first intercourse with their current partner, peer
approval, perceived susceptibility to acquire HPV, and beliefs about vaccine
effectiveness. However, participants who were sexually active within three months of
completing the survey, daily smokers, utilized illegal drugs within a year of the survey,
and had a lack of knowledge about the vaccine were not initiating the vaccine (Manhart
et al., 2011). The researchers also noted that parental approval was not a factor in vaccine
initiation (Manhart et al., 2011).
Daley et al. (2010) conducted a study with a convenience sample of 256
ethnically/racially diverse female college students, at a public urban university in the
southeastern United States. Many of the participants were white and unmarried/single.
Vaccine initiation was more common if information was received from three sources,
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health care providers, family, and media sources (Daley et al., 2010). For participants in
this study, factors that influenced declination of immunization were the belief that
vaccines cause illness and safety concerns (Daley et al., 2010).
Wolwa et al. (2013) conducted a study with 410 college women (217) and women
in a community health center (193), aged 18-46, 70% of the college women were ages
18-25 and 43.6% of community women were ≥ 46 years of age; the participants were
ethnically/racially diverse. The authors found that women in the college group, were
more likely to have received the vaccine, some factors that influenced initiation were
perceived seriousness of cervical cancer, and knowledge about HPV; while Pap testing
rates did not increase uptake (Wolwa et al., 2013).
Bynum et al. (2011) conducted a study of 363 African American females, ages 18
to 26, enrolled in three historically black colleges/universities in the southeastern US.
These researchers found that participants that would accept the vaccine perceived benefit
of the vaccine, had more cues to action, had a prior STI diagnosis, and age at first sexual
encounter (Bynum et al., 2011). When considering racial pride, it was found that the
more pride they had, the less likely they were to vaccinate (Bynum et al., 2011). In this
study, perceived susceptibility and severity did not predict vaccine intake; nor did health
care distrust or sexual history (Bynum et al., 2011)
Marchand, Glenn, and Bastani (2012) conducted a study with community college
women aged 18-26 in Los Angeles, California. The participants in this study were
recruited from an ethnically diverse student population with 55% reported as
Hispanic/Latino, 30% African American, 7.5% Asian American, and 7% White (Los
Angeles Community College District, 2011). The participants in the study were
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Hispanic/Latina (59%), African American (31.5%), Asian American (2.2%), White
(1.1%), and other (5.6%). The results of this study showed that women who initiated the
vaccine were younger in age, had a health-related field of study, perceived that the
vaccine was safe, thought that HPV severity was lower, and had a perceived higher social
approval for the HPV vaccination than vaccine naïve participants had.
D’Urso, Thompson-Robinson, and Chandler (2007) conducted a study with 351
Black undergraduate students enrolled at a historically black university located in the
southeastern United States. This study found that the participants were deficient in their
awareness of HPV (64%), learned of HPV once they had already been infected, and
gained knowledge about HPV from health care providers or college classes (D’Urso,
Thompson-Robinson, and Chandler, 2007). Based on the data gathered in this study,
preventative strategies for sexual health were inclusive of practicing monogamy,
maintaining an abstinent lifestyle, and utilizing condoms (D’Urso, Thompson-Robinson,
and Chandler, 2007). Thus, utilization of vaccination for sexual health was not
significantly practiced.
HPV Intention Research in Black College Students
Staples, Wong, and Rimel (2018) conducted a study with African American
college studetns at four HBCUs and found that early deection and primary prevention are
paramount to preventing disportaiante disparties in cervical cancer incidence and
treatment. This study also found that while the students had a 96% rating for knowledge
about HPV vaccine, a mere 52% had completed the vaccine (Staples, Wong, and Rimel,
2018). Although 52% of the students had begun the vaccination series, only 42% of the
partipants had completed the three vaccine series.
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LaJoie, Kerr, Clover, and Harper (2018) conducted a study to predict HPV uptake
in US male and female college students, overall, they found that one of the barriers to
vaccination was the fact that the participant’s partner was not vaccinated. This study also
found that uptake of the vaccine was positively influenced by parental influence and no
cost vaccination (LaJoie, Kerr, Clover, and Harper, 2018). LaJoie, Kerr, Clover, and
Harper (2018) also noted that involving the post adolescent young adult population are
crucial to helping to prevent cervical cancer.
In summary, the review of the literature in this section focused on female and
male college age students. Some of the factors that increased intention to vaccinate are
multifaceted and include: prior diagnosis with STIs, knowing someone with HPV, being
sexually experienced, perceived risk and vulnerability, knowing that HPV can help
prevent warts and cervical cancer, vaccine cost, parental/health care provider influence,
younger age, and perceived the HPV vaccine as safe. The factors that decreased intent to
vaccinate were just as interesting and some of the factors included: sexual activity, lack
of supplemental health insurance, diagnosis of genital warts, and recruitment settings.
HPV Vaccination Studies with Male and Female Participants
Lee, Lust, Vang, and Desai (2018) conducted a study of male undergraduates
found that 54.5% (n=2516) of participants, aged 18-20, completed the HPV vaccination
series. This study also found that age and the type of institution attended by the
participants had a positive correlation with HPV vaccine uptake (Lee, Lust, Vang, and
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Desai, 2018). While previous sexual encounters had not significant effect on vaccine
initiation Lee, Lust, Vang, and Desai, 2018). If the participants were enrolled in a 4-year
institution they were also more likely to have been vaccinated Lee, Lust, Vang, and
Desai, 2018).
Daley et al. (2011) reported that Hispanic and non-Hispanic White males have
more knowledge about HPV infection than African American men do. Vaccinating men
and women would deter the transmission of the virus between them as well as help to
shift the burden of STI prevention to both parties (Jones & Cook, 2008). The gender of
the participants in the studies varied, thus the intention for HPV vaccination fluctuated as
well. In a study by Ford (2011), young adult women with moderate to high levels of
awareness of HPV had low vaccination rates. This study viewed racial and ethnic
disparities in HPV awareness and vaccination. The participants in this study were one
thousand nineteen women aged 18-24. The women in this study self-identified their
ethnicity as Hispanic, non-Hispanic black or non-Hispanic white. This study also noted
that socioeconomic and health care barriers were apparent since the participants in the
study did not have health insurance and were less educated on HPV if they had not
received reproductive medical care (Ford, 2011).
Most of the studies that have been cited have been composed of female
participants, and the majority of studies in the HPV body of literature have focused on
women.
Widdice and Moscicki (2008) noted that 50% of American adolescents and young
women acquire HPV within three years of initiating sexual intercourse. It is reported that
the number of college students in the 18-24-year-old group increased over 16% and the
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majority of the freshman students were females (Snyder, Dillow, & Hoffman, (2009).
These women are at risks for adverse health outcomes, because of exposure to behavioral
and psychosocial factors, including unintentional or intentional injuries, unintended
pregnancy, and STI infection (CDC, 1996 & Linnehan & Groce, 1999). High risks types
of HPV if linked to 95-100% of women with cervical cancer, and those types are
estimated to cause 90-98% of cervical cancers worldwide (CDC, 2015a; Bosch & de
Sanjose, 2003; Munoz et al., 2003). Burak and Meyer (1997) found that college women
are at a higher risk for acquiring STDs than the general population because of the highrisk sexual behaviors.
According to the 2017 National College Health Assessment data (64.3%) of
females and 60.9% of males reported in engaging in vaginal, oral, or anal sex within the
last 12-month period (American College Health Association, 2018). In the sample of
males and females from the National College Health Assessment, condom use for oral
sex (5.3% each), vaginal sex (54.9% &46%), and anal sex (35.3% & 21.1%) was reported
for the 30 days (American College Health Association, 2018).
In relation to males, men often have more sex partners than women, are not
frequently tested for STI infections, and exhibit fewer symptoms of infections; thus, they
play a significant role in the transmission of HPV (Hippelainen et al., 1993) In a study,
looking at heterosexual sexually active male students in a university, aged 18 to 20, the
cumulative incidence of new infection with any genital HPV type was 62.4% over 2
years by (Patridge et al., 2007). So, there is no doubt that boys and men should be
vaccinated for HPV. Kim (2011) noted that vaccinating boys and men will have positive
health effects in girls and women, because it will reduce the risk of HPV in males, thus
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preventing exposure to their partners. The benefits of vaccinating males and females will
also help to equalize the burden of protection to both genders and not just females alone
(Kim, 2011). Fenkl, Hughes, and Jones (2016) conducted a study at a minority serving
institution and found that 60% (n=79 of 131) of the male participants didn’t know that the
HPV vaccine was available.
Wilson et al. (2017) conducted a study and found that participants were more
likely to receive the HPV vaccine if their freiends had also received it. They also found
that younger age, not being in a relationship, sexually active, and receivng a Papucaulna
screening postively effected the individuals who began the HPV vaccine series (Wilson et
al., 2017).
Ultimately the decision to become vaccinated varies between genders; what
increases intentions to vaccinate in one population can deter participants’ intentions in
another study. Intentions to vaccinate were widely diverse as in prevous studies. The
studies reviewed here did show that men are in important part of the puzzle to decreasing
STI spread (Kim, 2011 and Fenkl, Hughes, and Jones, 2016). A finding that became
evident during this review is that the type of institution the students studied at,
positivielly correlated with vaccine uptake (Lee, Lust, Vang, and Desai, 2018). Research
that explores gender and racial diversity is warranted in future studies involving HPV.
Racial Disparities
Wolwa et al. (2013) noted that HPV infection rates are higher in Hispanic and
African American women. Racial disparities also exist, since HPV- associated cervical
cancers affect Black women more than other women (CDC, 2018a). Dempsey, Cohn,
Dalton, & Ruffin (2011) noted that African American women aged 18-26 years were
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more likely than their white peers to initiate the HPV vaccine, but less likely to complete
the series. In a study by Ford (2011) 80% of the non-Hispanic Black women reported an
awareness of HPV infection and vaccination, but uptake of the vaccine across was only
8%.
African Americans have the disadvantage of having disproportionate distribution
of multiple negative aspects of unhealthy lifestyles, economics, family dynamics, and
mental illnesses. Numerous studies have found that African Americans distrust of health
care professionals has limited their utilization of primary, secondary, and tertiary health
benefits. This barrier makes it even more difficult to provide protection to the people who
would benefit the most. Scarinci, Garces-Palacio, and Partridge, (2007) found that
although African American women accepted the vaccine, they were hesitant to be
vaccinated because of family member or partner concerns about promiscuity or
unfaithfulness if the vaccine was received. Health care providers must employ strategies
to ensure that information provided regarding individuals’ cultural attitudes and
behaviors are included when providing information about HPV (Thomas, Yarandi,
Dalmida, Frados, & Klienert, 2015).
In summary, the health care community must utilize strategies that are ethnically
diverse, just like to populations they service. Review of the literature here depicts that the
burden of HPV resides in females (CDC, 2018a). The studies here also found that vaccine
uptake is positively influenced by the type of institution the students attended.
HPV in the Individual/Family/Community
31,200 cases of cancer each year, could be prevented by HPV vaccination (CDC,
2018f). This finding alone should energize health care providers to continue to educate
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families and offer HPV vaccination. Patel et al. (2012) noted that cervical cancer is the
second most common cancer among females and in many developing areas in the world it
ranks first. As the second most common cancer worldwide, cervical cancer affects half a
million women and more than half of the infected individuals die (Parkin, Bray, &
Ferlay, 2005 & Cutts et al., 2007). The HPV related cancer most occurring in women is
cervical cancer and in men oropharyngeal cancers (CDC, 2018a). HPV types 16 and 18
are associated with 70% of invasive cervical cancer worldwide (Bruni et al., 2017). Thus,
the impact of this disease affects individuals, families, and communities.
According to Bruni et al. (2017), in 2012, an estimated 527,624 women were
diagnosed with cervical cancer and 265,672 became fatalities from the disease. In the
world, cervical cancer ranks as the 4th most frequent cancer among women. In a
comparison between the Americas, Africa, Asia, Europe, and Oceania the Americas
ranked second in cervical cancer rates (Bruni et al., 2014) Bruni et al. (2014) also
indicated that worldwide mortality rates of cervical cancer are substantially lower than
incidence, with a ratio of mortality to incidence at 50.3%. Most of these cases are from
squamous cell carcinoma, with adenocarcinomas. In a comparison between the Americas,
Africa, Asia, Europe, and Oceania the Americas ranked second in cervical cancer rates
(Bruni et al., 2014).
In summary, the family unit has continued to be plagued with the result of HPV
infection. HPV effects the reproductive organs gastrointestinal system and can be
debilitating to the family since HPV is believed to cause 90% of anal and cervical
cancers, 50% of vaginal vulvar, and penile cancers, and 60 to 70% of oropharyngeal
cancers (CDC, 2018a).
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Geographic Location
Health outcomes in rural areas are poorer than urban areas; this is important to
note because 462. Million (14.8%) of the total US population reside in rural areas
(Matthews et al., 2017). The number of adolescents living in urban areas are being
vaccinated with the HPV vaccine more than their counterparts living in rural areas (CDC,
2018b). 39.5 million Americans identified themselves as non-Hispanic Black or African
American according to the US Census Bureau estimates from 2014 (American Cancer
Society (ACS), 2016). Of the 39.5 reported individuals, the majority of the Black
population in the US live in the South, (ACS, 2016). The American Cancer Society
(ACS) noted that African Americans have the highest death rates and the shortest
survival rates in the US for most cancers (2016). One might hypothesize that this
disparity is prevalent because of biological differences, but the truth is quite contrary.
There are social and economic disparities that influence this atrocious phenomenon.
Some of these inequalities include work, wealth, income, education, housing, and the
overall standard of living (ACS, 2013). There are other noteworthy barriers in the African
American community which include lower utilization of high-quality cancer prevention,
early detection, and treatment services (ACS, 2013).
In 2016, the estimated deaths for cervical cancer in African American women was
750 deaths (ACS, 2016). This is bewildering since it is estimated that 80% of deaths from
cervical cancer could be prevented by regular screening, follow up care, and treatment
(ACS, 2013). Cook et al. (2010) noted that Blacks were 44% less likely than Whites to
complete the vaccination series. While Widdice and colleagues (2011) noted that Black
patients were 50% less likely than whites to complete the 3 dose vaccination series.
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In a study conducted by Schluterman, Terplan, and Lydecker (2011) a lower
vaccination rate of 18% was noted in women, aged 18-26, in an urban hospital. Watson,
Saraiya, and Bernard (2008); Saraiya et al. (2007); and Singh, Miller, Hankey, and
Edwards (2004) noted that socioeconomic disparities in cervical cancer exists within
Black and Hispanic women and women living in areas with greater poverty. These
women also experience higher incidence and mortality rates (Watson, Saraiya, &
Bernard, 2008; Saraiya et al., 2007; and Singh, Miller, Hankey, and Edwards, 2004). In
the National Immunization Survey-Teen (NIS-Teen) it was noted that the threevaccination series was completed 70% (for Black adolescents, N=1,743), 74.5% for
Hispanic adolescents (n=3,882), and 60% for white adolescents, n=13,010 (CDC, 2018d).
In a study conducted by Niccolai, Mehta, & Hadler (2011) significant disparities were
observed in HPV vaccination by race/ethnicity and poverty, these data suggest that
cervical cancer development for those at most risk remain.
The US department of Health and Human services through the Healthy people
initiative have set a goal to increase the vaccination coverage level of 2-3 doses of human
papillomavirus (HPV) vaccine for females and males aged 13 to 15 years (USDHP,
2018). The adherence to the vaccine schedule has increased from 16.6% in 2008 (3
doses) to 30.0% in 2011 (3 doses) to 45.1% (2-3 doses) in 2016 (for females); and in
males the percent of males that received the recommended doses increased from 6.9% (3
doses) in 2012 to 36.4% (2-3 doses), in 2016 (USDHP, 2013b; USDHP, 2018b) Notably,
the initiation of the HPV vaccine in African American (56%) adolescent girls was higher
than in white girls (48%); but the completion of the series is lower (61% vs. 75%) (CDC,
2011). (CDC, 2010) noted in 2009 US adolescents 13-17 years of age was 44.3, ranging
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from 22.9% for Mississippi teens, to 69% in Massachusetts.
In summary, several studies found that there is a clear distinction for health
outcomes for individuals living in rural areas. There is also a majority of Black
Americans that live in the Southern areas of the United States. This information must be
taken into consideration when considering strategies to increase vaccination. Niccolai,
Mehta, and Hadler (2011) noted that to reduce disparities and achieve the vaccine’s full
potential, greater efforts are required to ensure completion of the vaccine series in Blacks
and other poor women.
HPV and Economic/Cost Considerations
The cost of HPV to the health care area is for diagnostic and treatment is about $6
billion dollars (Armstrong, 2010). This value could be significantly reduced if this
vaccination was adhered to consistently. The American College of Obstetricians and
Gynecologists (ACOG) recommends that women that are between the ages of 21-29 have
Pap test screening without HPV testing every 3 years: while women aged 30-65 should
have a Pap test and HPV test every five years (ACOG, 2017 from:
https://www.acog.org/Patients/FAQs/Cervical-Cancer-Screening).
Costs of HPV can be viewed in three categories: costs of cervical cancer
screening, cost of HPV associated cancers, and costs of genital warts. In a study by
Chesson et al. (2012) annual cost of follow-up for abnormal screenings was estimated to
be $1.2 billion dollars; this includes $0.4 billion for follow-up visits and treatments for
false positive Pap examinations and $0.8 billion for cervical intraepithelial neoplasia
(CIN). In the same study, genital wart cost was estimated to be between $410-$930 per
case (Hu & Goldie, 2008; Hoy, Singhal, Wiley, & Insinga, 2009). The estimated costs of
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HPV in the US are estimated by Chesson et al. to be $8 billion dollars (2012). Chesson et
al. (2012) noted that estimating the direct medical costs of prevention and treatment of
HPV associated diseases can help to quantify the economic burden of HPV and
demonstrate the potential benefits of HPV vaccination.
Adherence to HPV vaccination adherence is the presumed influence of the
pharmaceutical executives on the implementation of the vaccine. If the public perceives
profit will be greater than public protection, policy formation and acceptance of the
vaccination falters (Abiloa et al., 2013). Implementation of a full series of the HPV
vaccination can range from 360-600 dollars (Chesson et al., 2011). Outterson (2009)
noted that $360.00 for a three series vaccine series for HPV makes it the most expensive
vaccine series in human history.
Armstrong (2010) found that HPV vaccination can be cost effective with
incremental cost-effectiveness ratios (ICER) of 100,000 or less per quality-adjusted lifeyear (QALY) gained if administered to females aged 12 years in context of cervical
screening intervals of 1 year. This study also noted that catch-up vaccination through age
21 increases the cost per QALY to more than 100,000 (Armstrong, 2010). It should also
be noted that 75% of the costs of cervical cancer is attributed to decreased productivity of
the individual, deficiency of future earnings and other related factors (Max, Rice, Sung,
Michel, Breuer, & Zang, 2003).
Cost analyses have been conducted to determine vaccination cost effectiveness.
Brisson, Van de Velde, & Boily, (2009) noted that HPV vaccination of males and
females is not cost effective, but if only one gender, namely females, are being under
vaccinated, then the benefits outweigh the cost (Kim, 2011). When a comparison was

42

conducted between looking at vaccination of both genders versus girls only, costs
exceeded $100,000 per quality-adjusted life year (QALY) gained and the value reached
as much as $1 million per QALY gained (Brisson, Van de Velde, & Boily, 2009).
Consequently, based on the uptake of the vaccination it would be cost effective to
vaccinate boys and men (Kim, 2011).
In summary, the cost implication for HPV include considering the cost to
individuals, families, and society. Although cost should not be a determinant to live
saving vaccination it is. The health of the citizens of a society should not negatively be
influenced by monetary factors alone. In order to utilize our resources to improve the
health and welfare of US citizens, we have an obligation to efficiently use assets
efficiently (Kim, 2011).
HPV Policy Implications
The decision to approve the vaccine in 2006 was a catalyst in the political arena.
Law makers were faced with the challenge of implementing and promoting the utilization
of the HPV vaccine. Consequently, in 2007 legislation regarding HPV vaccination had
been introduced in forty of the fifty states (National Conference of State Legislatures,
2009). Abiola, Colgrove, and Mello noted that politics play a major role in health policy
formation, public preferences, interest group involvement, and partisan ideology (2013).
In the implementation of this vaccine, this has belief remains prevalent. Although this
vaccine has been added to the recommended vaccine series, cost and practicalities of a
multiple dose vaccine series must be considered before a true national adherence to the
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recommendation will be successfully implemented. The debates continue about utilizing
this vaccine, one belief is that administering the vaccine send mixed messages about
abstinence and premarital sex; others believe that providing this vaccine give children a
“license” to participate in sexual intercourse (Vamos, McDermott, & Daley, 2008).
Currently, there are several strategies that are being implemented on the state
level to address the HPV vaccination. According to the study conducted by Abiola et al.
(2013) these strategies include: policy mandates, no policy at all, requiring insurance
coverage for the vaccination cost, educational strategies that allow parental acceptance or
declination, unbiased education coverage of the HPV information, legislative
appropriated funds for the promotion of the vaccine, addition of the vaccine to the state
immunization program without cost, and formal legislation requiring vaccine adherence
for sixth grade enrollment while still allowing parents to opt out.
In summary, economic and cost considerations related to HPV include multiple
factors that are inclusive of policy. The implementation of the vaccine can be influenced
positively or negatively by policy makers.
Prevention
HPV vaccination can significantly reduce the health and economic burden
associated with cancers caused by HPV viruses. Jones and Cook (2008) noted that the
HPV vaccine was expected to reduce health care costs, emotional burdens, and
embarrassment caused by the diagnoses of genital warts and or abnormal Papanicolau
(Pap) results. Yet the vaccine may be inaccessible to those who need it the most secondary
to inability to afford the vaccine series (Erdman, 2008). There are numerous studies that
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have been published that indicate the implementation of the vaccine in girls is costeffective and reduces the burden to the public health care system. Chesson et al. noted that
vaccine that there is a correlation between implementing vaccine coverage in males and
females (2011). They noted that the vaccine coverage in males was dependent on the
coverage in females (Chesson et al., 2011). It was also found that it would be more cost
effective to increase vaccination in 12-year-old girls than to add male vaccination (Chesson
et al., 2011). While vaccination is a solution to preventing HPV, other primary preventions
are necessary; knowledge and awareness of HPV prevention and transmission are also
paramount.
The Health Belief Model and HPV Intentions
The Health Belief Model (HBM) has been used as the theoretical framework for
numerous studies that explored health promotion and health-related behaviors. As
discussed in Chapter 1, the HBM explains individuals’ behaviors based on their personal
beliefs or perceptions about disease process and the strategies to detour the diseases
occurrences (Clark & Paraska, 2012). This theory was originally composed of four
constructs, (perceived: seriousness, susceptibility, benefits, and barriers), but has evolved
to include cues to action, motivating variables, and self-efficacy (Clark & Paraska, 2012).
This model also suggest that an individual’s preventative health behaviors are dependent
on perceived susceptibility to disease, the severity of health outcomes, the benefits of and
barrier to behavior engagement, and cues to motivate (Rosenstock, 1974).
HPV and Perceived vulnerability
Social media is a trend that is here to stay, ultimately it influences our decisions
regarding almost every aspect of live. Stephens & Thomas (2014) conducted a study and
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found that social networks were persuasive to college women, with internet sites, close
family, and health care providers being the favored social networks for HPV vaccine
information. The male and female participants in the study conducted by Barnard,
George, Perryman and Wolff (2017) had a low perception of their risks of contracting the
HPV virus. 24.8% of the male students thought they were at risk, while only 21.9% of
female students thought they were at risk. This study was conducted at a public univeristy
in Missippi, and had a 13.1% response from Black participants.
HPV and Perceived severity
Thompson et al. (2017) utilized the data collected from the National College
Helath Assessment Survey II, gathered from US college and university male and female
students, to determine if associations existed between demographic characteristics, health
status, receipt of health services, college region and size, sexual health information and
HPV vaccination status. In female partidcipants they found that ethnic miniorities,
students that attended schools located in the Southern areas, and not receiving or unsure
of when they last had gynecological services, were less likely to report receiving the HPV
vaccine. In male participants it was noted that African Americans, students attending
school in Southern or Western areas, and receiving information on STIs were more likely
to receive the HPV vaccine.
HPV and Perceived benefits
While, individuals gain knowledge about HPV from varying sources, health care
providers continue to play a pivotal role in informing patients about the benefits of
vaccination (Jones, Mathis-Gamble, & Fenkl, 2017; Stephens, Tamir, & Thomas, 2016).
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Stephens, Tamir and Thomas (2016) also noted that a difference in knowledge regarding
HPV vaccine was notable among HPV vaccine naïve females and females that received
that HPV vaccine.
HPV and Perceived barriers
Thomas, Stephens, Jonhson-Mallard, and Higgins (2016) noted that cost of the
vaccine was would be a barrier to only 24.1% (28/116) of the male participants in their
study. Barnett et al. (2016) found that students enrolled at HBCUs have disparities that
put them at risk for not receiving health services that offer HPV vaccination or Pap tests.
It was found that only 18% of HBCUs compared with 53% of nonHBCUs offered HPV
vaccination, and 50% compared to 76% of non HBCUs offered Pap tests. This only
marginalizes this community more.
In summary, studies that explore constructs of the HBM in relatin to HPV found
that the participants in these studies have a low perceived vulnerabilty to HPV; that the
perceived bevefit varied in vaccine naïve individuals and the sourece of knowledge also
varied; and finally that a barrier was being a student at a HBCU due to decreased health
services, specifically gynecological services.
Other Factors: HPV and Trust/Distrust
Freed et al. (2011) conducted a study to determine how parents trust vaccine
information that is provided by varying sources. The researchers found that vaccine
information was trusted from physicians, other health care providers, government vaccine
officials, and family and friends (Freed et al., 2011). Cuffee et al. (2013), found that trust
of medical providers within a sample of African American males and females helped
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participants adhere to treatment regimens. In a study conducted by Boulware et al. (2003)
it was found that non-Hispanic Black participants were concerned about personal privacy
and potential for harmful experiments in hospitals; and trusted their physicians less.
HPV and Social Influence
In a study conducted by Thomas, Bluming, & Delaney (2015) in a rural
community, it was found that community churches and faith based approaches would
benefit HPV prevention and vaccine uptake of the vaccine. An important implication of
this study showed that spirituality, religiosity, and faith based context are important
influences for HPV and other health promotion activities (Thomas, Bluming, & Delaney,
2015). Hirth et al. (2018) noted that during their study in college studetns four themes
materalized, one of which was social influences. Interestigly, this study found that
although participants valued inforamtion from their peers describing their experiences
after receiving the vaccine, they did not have faith in their peers opinions.
In a study completed by Barnard, George, Perryman and Wolff (2017) it was
found that sources of informtion about HPV and the vaccine came from internet sources
and educational settings for male college students, and from educational settings and
from health care providers in female college students. This study also found that only
21.6% (n 114) of males, compared with 62.4% (n 269) of females had the HPV vaccine
seiress recommended to them by a physician or nurse.
HPV and Past sexual behavior
Since HPV can be spread via sexual contact, it is hypothesized that there would
be a relationship between sexual practices and HPV vaccine adherence. In a study of
African American women conducted at an HBCU, it was found that 68% (68/100) of the

48

participants had 1-3 sex partners in the past year, while only 40% (40/100) had received
the HPV vaccine (Thomas & Freeman, 2011). The participants in studies conducted by
Jones & Cook (2008), Bendik, Mayo, & Parker (2011), and D’Urso, ThompsonRobinson, & Chandler (2007), intentions to vaccinate were higher. Yet in studies by Patel
et al. (2012), Manhart et al. (2011), and D’Urso, Thompson-Robinson, & Chandler
(2007), participants had lower intentions based on sexual practices. Sexual practices are
significant to exposure to HPV, thus data regarding this should be utilized when
considering strategies to increase HPV vaccination and decrease HPV exposure. Sexual
behaviors of an ethnically and racially diverse group of male and female college students
in a study conducted by Thomas et al. (2015) found that in the 12 months prior to the
study the majority participants reported having male sex partners, engaging in petting
behaviors, oral sex and penile vaginal intercourse. In a study conducted by Oswalt and
Wyatt (2013), 49.2% (n7503, N-16,243) of the heterosexual female participants denied
receiving the HPV vaccine.
Data collected from the participants in the study by Bynum et al. (2011) revealed
that prior STD exposure increased the likelihood of receiving vaccine (Bynum et al.,
2011); while an inverse, relationship was noted in the study by Jones and Cook (2008).
While the participants in the study conducted by Manhart et al. (2011) had an increase in
knowledge with just the risk HPV exposure. This data suggests a wide spectrum of
intentions related to STD exposure, thus continuing to explore this variable in future
research is valuable. Thomas and Freeman (2011) found that 45% (45/100) of the college
women enrolled in a HBCU had a prior diagnosis of and STI.
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Conclusion
In conclusion, the review of the literature found a variety of factors that were
associated with intent to vaccinate for HPV. Some of the factors that increased intention
to vaccinate are multifaceted and include: prior diagnosis with STIs, knowing someone
with HPV, being sexually experienced, perceived risk and vulnerability, knowing that
HPV can help prevent warts and cervical cancer, vaccine cost, parental/health care
provider influence, younger age, and perceived the HPV vaccine as safe. The factors that
decreased intent to vaccinate were just as interesting and included: sexual activity, lack of
supplemental health insurance, the health care community must utilize strategies that are
ethnically diverse, just like to populations they service. The review of the literature also
notes that the burden of HPV resides in females (CDC, 2018a). Another finding was that
vaccine uptake was positively influenced by the type of institution the students attended.
Ultimately the decision to become vaccinated varies between genders; what increases
intentions to vaccinate in one population can deter participants’ intentions in another
study.
When it comes to risky sexual behaviors, STI knowledge is not a protective factor
to prevent infection (Younge et al., 2013). In summary, besides studies of HBM
constructs, studies have explored other factors that are related to HPV intentions.
Students that attend HBCUs represent 25% of the African American college graduates
and being a student at an HBCU puts individuals at greater risk for STI infection
(Whitehouse, 2013). Research that explores the relationship between HPV awareness and
vaccine uptake related to these barriers, in diverse young adults, and that has various
geographic regions is needed in this area to further expand the body of knowledge.
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Thomas, DiClemente, and Snell (2014), noted that to develop impartial and beneficial
health promotion programs, geographic factors must be taken into consideration. This
increase in understanding will help to better inform the development of more effective
public health interventions programs. If vaccination is to be successful it must become a
regular health promotion activity, but in order to do this respect must be a building block
of the relationship between health care professionals and their clients (Thomas, 2016).
Then, programs can target and eliminate racial, gender, and geographic health disparities
in HPV treatment and care.
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Chapter 3 Research Design and Methodology
Description of the Research Design
The research study was a descriptive study to determine HPV vaccine intentions
in vaccine naïve young Black college students. A non-experimental cross-sectional
research design was used. A cross sectional design was chosen because this data was
examined at one point in time; the study estimated prevalence of intention to vaccinate in
a small representation of young Black college students; and study findings will aid in
future public health planning (Levin, 2006).
Setting
The study sample was recruited from minority serving institutions (MSI) of
higher education, including historically black colleges and universities (HBCU), in rural
and urban geographic locations in the United States.
A cross sectional design was utilized for this study. The convenience sample
included participant students recruited from Tuskegee University in rural Tuskegee,
Alabama; Florida Memorial University in urban Miami, Miami Dade College in Miami;
and Florida International University (FIU) in urban Miami, Florida. Tuskegee University
and Florida Memorial University are HBCUs while Miami Dade College and Florida
International University are Hispanic-serving MSIs. The sample population included
male and female individuals that self-identified as Black/African descent, ages 18-24,
enrolled as a student at one of the university systems, self-identified as HPV vaccine
naïve, and able to speak and read English. The participants completed a self-administered
survey.
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Population
As of July 2015, the United States (U.S.) had an estimated population of
321,418,820; and of this number 13.3% of them were Black or African American (United
States Department of Commerce, n.d.). However, they have the greatest burdens of STI
infection in the United States (CDC, 2015b). HPV is a virus that can cause cancer. Bruni
et al. (2015) noted that the primary route of transmission of genital HPV infection is
sexual intercourse. The virus can lead to genital warts or anogenital cancers, involving
the vulva, vagina, and cervix of females, the penis of males, and the anus and rectum of
both genders (CDC, 2015a).
In comparison with their White counter parts, Black women had higher rates of
HPV-associated vaginal cancer, but lower rates of vulvar and oropharyngeal cancer
(CDC, 2019b). In 2013, the estimated deaths for cervical cancer in African American
women was 720 deaths (American Cancer Society (ACS), 2013). Black women also have
a higher rate of deaths related to cervical cancer (CDC, 2016c).
Also, 50% of all new STIs in the United States are in young people aged 15-24
(CDC, 2017a). This is of concern since they only account for 25% of sexually
experienced population (CDC, 2017a). Within these new cases 49% of them are in young
males and 51% in young females; of these, HPV accounts for the majority of the newly
acquired STIs (CDC, 2013). Although the HPV vaccine is available, 6 out of 10 girls and
5 out of 10 boys in the United States have initiated vaccination (CDC, 2016b). College
students are at an age where they can independently make decisions about their health
and receiving vaccinations, such as HPV; thus, they need education and strategies to aid
them in their decisions.
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Sample
Description of Sample. A convenience sample was used to gather information
from a volunteer sample. For this study, this method was chosen because of the intimate
nature of the questions and the answers individuals must make regarding their health
behaviors. The sample was composed of male and female Black/African descent college
students, ages 18-24.
Sample Size and Power Analysis. The major factors involved in sample size are
significance level, power, and the magnitude of the difference (effect size) (McCrumGardner, 2010).
This study was conducted using nonprobability sampling method, convenience sampling
(Polit & Beck, 2004). In this study, the data solicited is about health intentions and past
sexual behaviors, thus this sampling method may produce more participants. The sample
size for this study was a minimum of 143 students, this is based on medium effect for the
error of probability. This analysis was conducted with the G*Power 3.1 software utilizing
a chi square test, with a DF of 5, an error probability of 0.30 (medium effect), and power
of 0.8 (McCrum-Gardner, 2010). This test was calculated using the small (0.10) and large
(0.5) effect size as well. When the small effect is used the recommended sample, size is
1283. When the large effect size is used the recommended sample, size is 52.
Inclusion Criteria. The inclusion criteria for this study were as follows:
1.

Self-identified as Black/African descent male or female

2.

Self-identified as HPV vaccine naïve

3.

Self-identified as an enrolled college student at one of the study sites.

4.

Self-identified as an age of 18-24 years old
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5.

Ability to read, speak, and understand the English language

6.

Currently residing in a rural area if they attend an institution located in a
rural area

7.

Currently residing in a urban area if they attend an institution located in an
urban area

8.

An undergraduate or graduate student

9.

Non-married

10.

Willingness to participate

Exclusion Criteria. Participants were excluded from the study if:
1.

Failure to self-identity as Black/African descent American

2.

Failure to self-identify as vaccine naïve

3.

Reports being younger than 18 or older than 24 years old

4.

Not currently enrolled at one of the identified institutions

5.

Currently reside outside of the rural area if attending a school in a rural
location

6.

Currently reside outside a urban area if attending a school in a urban
location

7.

Reporting a married status

Sample Recruitment. The researcher recruited participants by passing out flyers
and sending email announcements. At all locations, recruitment was done via word of
mouth, posted flyers, class announcements, and email announcements. Recruitment took
place 1-2 days before data collection in each perspective site.
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Control Variables. There were no control variables in this study.
Procedures
Following institutional review board (IRB) approval from all sites, flyers were
posted including study purpose, recruitment information and requirements for the study.
The recruitment material included contact information for the interested participants to
inquire about the study. Recruitment material were distributed in student congregant
areas, residence areas, libraries, and educational buildings. After making arrangements
with the appropriate staff at each site, data collection took place at a designated area. This
included an area for students to complete the paper and pencil surveys. Upon arrival
students received a letter describing the purpose of the study and verbal informed consent
was obtained. The participants were given the survey packet and afforded an opportunity
to complete it.
As a token of appreciation for their participation in the study, participants were
given a $5.00 gift card. Funding for the gift cards came from a research grant that the
researcher received.
Instrumentation
The research questions that guided this study were: 1) Is there a difference in
demographics (age, gender, geographic location) between Black college students who
intend to receive the HPV vaccine and those who do not intend to receive the vaccination?
2) What are the relative contributions of perceived: vulnerability, severity, benefits, and
barriers to HPV vaccination intention among male and female Black college students? 3)
What are the relative contributions of trust/mistrust, social influence, and prior sexual
behavior to HPV vaccination intention among male and female Black college students? 4)
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Has the new practice recommendation to change the HPV vaccination series from a 3-dose
to a 2-dose series for young girls and boys caused a difference in intent to vaccinate for
male and female Black college students?
There were several variables addressed in this study. The dependent variable was
intention to vaccinate. The demographic variables/modifiable factors were age, gender,
and geographic location. The independent variables were perceived vulnerability,
perceived severity, perceived benefits, perceived barriers, trust/distrust, past sexual
behavior, social influence, dosing recommendations.
Demographics. A demographic data questionnaire was utilized to accumulate
data on the participants: age, gender, level in undergraduate education, race, sexual
orientation, religion, dating/relationship status, sexual experience history, place of
residence prior to school, health insurance status, reproductive health screenings, location
of screenings, prior diagnosis of sexually transmitted infections (STIs), recipient of HPV
vaccine, income of participant, and income of guardian/parent.
Student Human Papillomavirus Survey. The student human papillomavirus
survey (SHPVS) is a 27-item instrument designed to review students’ perceived
benefits/barriers to HPV vaccination (Thomas, Dalmida, & Higgins, 2016). This
instrument was used to measure the perceived vulnerability, severity, benefits, and
barriers for this study. The SHPVS authors collected data with a sample of 527 male and
female college students in a large urban university located in the southeastern United
States (Thomas, Dalmida, & Higgins, 2016). This 27-item instrument was scored using a
5 choice Likert scale, when the scores are tabulated, they can range from 0-108; with
higher scores equating to more knowledge and increased intentions to be vaccinated with
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the HPV vaccine (Thomas, Dalmida, & Higgins, 2016). Higher scores indicated that the
participants had higher perceived benefits, vulnerability, severity, or barriers related to
HPV vaccine (Thomas, Dalmida, & Higgins, 2016). Most of the participants in this study
were female 67% (353), ages 17-25, with Hispanic 66.8% (352), Black 14.2% (75),
White 12.3% (65), or other 6.7% (35) ethnicity (Thomas, Dalmida, & Higgins, 2016).
The overall Cronbach’s alpha for this instrument within these participants was 0.74
(Thomas, Dalmida, & Higgins, 2016).
A question was added to the end of this survey to solicit data regarding the
intention to receive vaccination now that the dose recommendation for the vaccine series
had been modified from 3 doses to 2 doses. The addition of the question resulted in an
increase from 27 items that are included in the scale to 28 items.
Health Care System Distrust Scale. The Health Care System Distrust Scale
(HCSDS) was created to measure distrust of the health care system (Rose, Peters, Shea,
& Armstrong, 2004). This scale was used to measure the variable of trust/distrust. This
10-item scale is scored on a 5-point Likert scale (Rose, Peters, Shea, & Armstrong,
2004). The total score for the instrument is 10-50, with higher scores indicated more
distrust.
This instrument was used in a study of 400 male and female participants with
30.4% (156) of them being African American (Rose, Peters, Shea, & Armstrong, 2004).
However, this scale has not been used in male and female Black college students. The
age of the participants was between 19 and 73 and the sample was recruited from a
Municipal Court in Philadelphia (Rose, Peters, Shea, & Armstrong, 2004). The
Cronbach’s alpha was 0.75 for the entire scale (Rose, Peters, Shea, & Armstrong, 2004).
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Sexual Risk Survey. The sexual risk survey (SRS) is a instrument that has 23
items and was designed to assess risky sexual behaviors that individuals have participated
in within the past six months prior to completing the survey (Turchik & Garske, 2009).
The SRS was used to measure sexual behavior in this study. The items are scored on a
scale from 0-4 and the possible total score range for the instrument is 0-92 (Turchik,
Walsh, & Marcus, 2015). When the survey score is tabulated, higher scores indicate a
greater risk-taking behavior (Turchik, Walsh, & Marcus, 2015). The internal consistency
of the total instrument was 0.90, when it was used with 5,496 male and female college
students (Turchik, Walsh, & Marcus, 2015). The study sample was derived from 18
distinct archived samples from 16 academic institutions coming from 11 different states
within the United States (Turchik, Walsh, & Marcus, 2015). This sample included
participants 21 years or older, with 65.2% (3585) female students, 45.9% (2519)
identified as ethnic minority, 3.8% (211) identified as a sexual minority, and 25.8%
(1420) as Christian (Turchik, Walsh, & Marcus, 2015). In this study, Black participants
total SRS score had an internal consistency of 0.90, females total score for internal
consistency was 0.89, male score for internal consistency was 0.92, individuals ≤ 20
score for internal consistency was 0.90 and individuals ≥ 21 score for internal consistency
was 0.90 (Turchik, Walsh, & Marcus, 2015). In a prior study by Turchik and Garske
(2009) with undergraduate male and female college students that were mainly Caucasian,
the internal consistency was 0.88 for the total score.
Perceived Social Influence on Health Behavior Instrument. The Perceived
Social Influence on Health Behavior Instrument (PSI-HB) was created to assess the
perceived role of others in health behavior decisions of individuals (Holt et al., 2010).
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This instrument was used to measure social influence in this study. This scale has 10
items that are scored using a 4-point Likert scale (Holt et al., 2010). The total score could
range from 10-40, with higher scores being indicative of higher levels of belief that
others effect an individual’s health behavior (Holt et al., 2010). Although this instrument
has not been utilized in a sample with young adult Black males and females, it was tested
in African American ≥ 21 years of age (Holt et al., 2010). This sample included 1006
African American participants, 69% (693) female and 31% male (Holt et al., 2010). The
internal consistency for this instrument in this population was 0.90 (Holt et al., 2010).
Data Management and Analysis Procedures
Data Management
Data was collected using a demographic instrument and 4 survey questionnaires.
The researcher was responsible for ensuring confidentiality and protection of all study
materials. The data was collected by the researcher. The researcher was present at the
collection sites to clarify information and answer any question that may arise. After the
questionnaires were completed and collected, they were stored in a locked box until they
were scored. The questionnaires were scored by the researcher. The questionnaires were
secured in the lock box when they were not being scored or not being entered into the
data base. The lock box was stored in the researcher’s primary residence. The researcher
entered the data into the SPSS version 24, via a password protected computer and
password protected file.
The surveys will be stored in a locked receptacle until such time that they can be
destroyed as outlined by the IRB expiration date. Once data entry was completed, the
researcher examined the data base for potential errors in data entry or distribution. The
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data was stored on a mass storage device and then data analysis ensued. Collected
surveys were assigned an alpha numeric code by the researcher. This number was used to
differentiate between locations and assist with data entry accurateness.
Analysis Procedure
Descriptive data analysis was completed on the data gathered from the
demographic instrument. The scores were tabulated for the SHPVS, including the 4 sub
scales, HCSDS, PSI-HB, and SRS.
Research Questions 1: Is there a difference in demographics (age, gender,
geographic location) between Black college students who intend to receive the HPV
vaccine and those who do not intend to receive the vaccination? The analysis for this
section included an independent t-test for the age analysis and chi-square goodness of fit
test for homogeneity difference exist the demographics in students that intend to
vaccination (Group 1) and students that do not intend to vaccinate (Group 2).
Research Question 2: What are the relative contributions of perceived:
vulnerability, severity, benefits, and barriers to HPV vaccination intention among male
and female Black college students? Binomial logistic regression was used to examine this
question to discover the relative contributions of perceived: vulnerability, severity,
benefits, and barriers among males (Group 3) and females (Group 4).
Research Question 3: What are the relative contributions of trust/mistrust, social
influence, and prior sexual behavior to HPV vaccination intention among male and
female Black college students? Binomial logistic regression was used to examine this
question to discover the contributions of trust/mistrust, social influence, and prior sexual
behavior among males (Group 3) and females (Group 4).
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Research Question 4: Did the new practice recommendation to change the HPV
vaccination series from a 3-dose to a 2-dose series for male and females influence intent
to vaccinate for Black college students? The analysis for this section was conducted using
a binomial logistic regression.
Human Subjects Considerations
1. Subjects involvement and characteristics:
Participant confidentiality was ensured by assigning each participant a code number. The
code number was used for all data collection. Names of participants were not used or
entered on the data collection instruments.
2. Sources of materials:
All materials used in the study were kept in a locked box in the researcher’s private
residence.
3. Recruitment and informed consent:
Participants were recruited via posted flyers, word of mouth, and email announcements at
the identified institutions. After verbal informed consent was obtained, the participants
were given the survey packet. Participants were advised that their participation was for a
one-time event, and the process would take less than 60 minutes.
4. Potential risks:
The participants were informed that there was no physical risk involved in this study.
However, there is a possibility of emotional uneasiness when they are answering the
questions about past sexual behavior. The students were informed that the survey was
anonymous and that their information would be kept confidential and reported as
aggregate data. They were advised that they did not have to answer any question that they
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feel uncomfortable answering. They were advised that their participation would not
endanger or benefit their enrollment/grades in the institution where they are enrolled, and
that there was not a fee to participate in the study. They were also informed that they can
halt participation in the study at any time, and they would still receive a gift card for their
participation. The students received the email address for the researcher and were advised
that they could contact her if they had any questions or wanted further information
regarding the study. The binomial logistic regression students were offered a copy of the
informed consent. Finally, students were advised that they could contact the FIU Office
of Research and Integrity by telephone at 1-305-348-2494 or by email at ori@fiu.edu for
further questions regarding the rights of human subjects or ethical concerns.
5. Protection against risk:
The students in this study were informed that there was no physical risk associated with
participation in this study. They were also informed that some of the questions were of a
sensitive and sexual manner, and this may cause them to feel uneasy. They were
instructed to omit answering any question that they were not comfortable answering.
They were reassured that their answers and consent will be kept in confidence. They were
also informed that the surveys would be protected by a lock box and would be kept in the
researcher’s private residence.
6. Benefits:
As a gesture for participating, students received a gift card. This was offered whether
they completed all of the survey questionnaires. They were also told that the information
gathered from this study will aid researchers in promoting sexual reproductive health of
Black college students.
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Inclusion of minorities. Black males and females were recruited for this study.
The institutions where students were recruited from were identified as HBCUs and/or
MSIs. HBCUs have a population consisting of mainly Black students, while MSIs have a
large number of minority students.
Inclusion of women and children. Women aged 18-24 years were included in
this study. However, no one under the age of 18 years was allowed to participate in this
study.
Data and Safety Monitoring Plan. This is not applicable, as the proposed study
was not in any phase of a clinical study.
Vertebrate animals. There were no animals involved in this study.
Study Limitations
The study limitations were as follows:
1.

Some of the instruments used in this study have not been used in a young

Black male and female college student population. However, except for the
demographic instrument, all instruments have been used with adult Black or
African American males and females.
2.

The data obtained from this study may not be applicable to all Black

students attending a HBCUs or MSIs or to Black people that do not attend college.
Summary
In summary, the data produced from this study is a fundamental building block
for researchers, clinicians, policy makers, and educators, in that it can aid in the
implementation of interventions that are timely, culturally relevant, and specific for this
population. This study provided insight into intentions of Black college male and female
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students, to receive the HPV vaccine, which will ultimately decrease the incidence of
cervical cancer.
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Chapter 4: Data Analysis
Introduction
This study’s purpose was to assess perceived vulnerability, perceived severity,
perceived benefits, perceived barriers, and risk behavior factors (trust/mistrust, social
influence, and prior sexual behavior) regarding intent to initiate and complete the HPV
vaccination series. The study was conducted with HPV vaccine naïve, Black college
students aged 18-24. These students were enrolled in a historically black
college/university (HBCU) and/or a minority serving institution (MSI). This quantitative
descriptive study is non-experimental and has a cross sectional design.
The study addressed the following research questions:
1. Is there a difference in demographics (age, gender, geographic location) between
Black college students who intend to receive the HPV vaccine and those who do
not intend to receive the vaccination?
2. What are the relative contributions of perceived vulnerability, perceived severity,
perceived benefits, and perceived barriers to HPV vaccination intention among
male and female Black college students?
3. What are the relative contributions of trust/mistrust, social influence, and prior
sexual behavior to HPV vaccination intention among male and female Black
college students?
4. Has the new practice recommendation to change the HPV vaccination series from
a 3-dose to a 2-dose series for young girls caused a difference in intent to
vaccinate for college students, and is there a difference between male and female
Black college students?
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The hypotheses that guided this study are:
1. There is a difference in demographics (age, gender, geographic location) in Black
college students who intend to vaccinate and those that do not.
2. Higher perceived vulnerability, perceived severity and perceived benefits scores,
and lower perceived barriers scores will be associated with increased intentions to
receive vaccination in Black college students who intend to vaccinate.
3. Trust, social influence, and prior sexual behavior will have a positive effect on
intent of Black college students to receive the HPV vaccination.
4. The decrease in the vaccine series dosing from 3 doses to 2 doses will have a
negative effect on Black college student’s intentions to vaccinate.
5. Gender will play a role in the decision to vaccinate based on the change in HPV
Vaccination policy for the number of doses for young adolescents.
Recruitment/Data Collection
After approval from the IRB from all participating institutions, flyers were posted
in multiple locations on campuses. Data collection took place in classrooms or designated
areas at each site. Students were provided with the consent form, and once verbal consent
was received, they were given the hard copy of the survey instruments. The participants
completed a self-administered survey. Upon completion of the survey they were given a
$5 gift card.
Sample Characteristics
The study sample was recruited from two HBCUs and two MSIs. The HBCUs are in a
rural and urban area in the southeastern United States. The MSIs are in an urban area in
the southeastern United States.
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The sample population included 160 participants. The participants were male and
female, ages 18-24, enrolled at one of the university systems during the time of the study,
self-identified as Black, self-identified as HPV vaccine naïve, and able to speak and read
English.
Data Collection Instrument
A demographic data questionnaire was utilized to accumulate data on the
participants including: age, gender, level in undergraduate education, race, sexual
orientation, religion, dating/relationship status, sexual experience history, place of
residence prior to college attendance, health insurance status, reproductive health
screenings, location of screenings, prior diagnosis of sexually transmitted infections
(STIs), recipient of HPV vaccine, income of participant, and income of guardian/parent.
The independent variables of age, gender, race, and location of university were analyzed
to provide summary statistics for demographic information on the sample (Tables 1-3).
One hundred percent of the participants in this study identified as Black. The percentage
of Black students, based on gender (N=152), who did not intend to vaccinate for HPV
was 69.7% (n=106).

68

Table 1
Number of Participants in each Age Category at the Time of Data Collection (N=160).
Age
18

n
35

%
21.9

19

31

19.4

20

18

11.3

21

23

14.4

22

24

15.0

23

21

13.1

24

8

5.0

160

100.0

Total

Table 2
Gender (N=160).
Gender

n

%

Male

55

34.4

Female

104

65.0

Missing

1

0.6

Table 3
College/University Location
Location

Frequency

Percent

n

%

FLORIDA INTERNATIONAL UNIVERSITY

8

5.0

MIAMI DADE COLLEGE

16

10.0

TUSKEGEE UNIVERSITY

36

22.5

FLORIDA MEMORIAL UNIVERSITY

100

62.5

Total

160

100.0
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Research Question 1
Question: Is there a difference in demographic characteristics (age, gender, rural
versus urban geographic location) between Black college students who intend to receive
the HPV vaccine and those who do not intend to receive the vaccination?
Hypothesis: There is a difference in demographic characteristics (age, gender, rural
versus urban geographic location) in Black college students who intend to receive the
HPV vaccine and those that do not.
Measurement Instrument: Data were collected using a Demographic Data Questionnaire.
Results for Research Question 1
The percentage of Black students who did not intend to vaccinate for HPV was
69.7%. This indicates that a large majority of Black college students in this study had no
intention to vaccinate for HPV.
Age Independent t-test
An independent t-test was calculated to determine whether there was a difference
between the age of participants and their intent to receive the HPV vaccination. One
hundred and fifty-three students reported their date of birth. Of this group, there were 106
participants that did not intend to receive the vaccination, while 47 participants intended
to receive the vaccination. The mean age of participants that did not intend to vaccinate
was 21 (M=20.62, SD=1.97). The mean age of participants that intended to vaccinate was
20 (M=20.11, SD=1.76). There was homogeneity of variances for the intent to vaccinate,
as assessed by Levene’s test for equality of variances (p=0.187) (Table 4). The
individuals that did not plan to vaccinate had a score of 0.52, 95% confidence interval
(CI) [-0.14 to 1.18] as did the individuals that decided not to vaccinate 0.52, 95% CI [-
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0.19 to 1.15]. There was not a significant difference in age and intent to vaccinate in
Black college students, t (151) =1.54, p=0.125, d=0.245. There was not a statistically
significant difference in the mean age of individuals that intended to vaccinate and those
that did not, t (97.99) =1.61, p=0.11. Therefore, the null hypothesis is accepted, and the
alternative hypothesis was rejected. (See Table 4).
Table 4
Age Independent Samples t-Test
Levene's Test
for Equality
of Variances

t-test for Equality of Means
95% Confidence
Sig.
(2-

Equal

Mean

Std.

Interval of the

Error

Difference

Differe Differe

F

Sig.

t

df

tailed)

nce

nce

Lower

Upper

1.756

.187

1.544

151

.125

.51626

.33426

-.14418

1.17670

1.613

97.987

.110

.51626

.32009

-.11895

1.15146

variances
assumed
Equal
variances not
assumed

Gender Chi-square
A chi-square goodness of fit test for homogeneity was calculated comparing the
gender of Black college students’ in relation to their intent to receive the HPV
vaccination. All expected cell counts were greater than five. One-hundred and fifty-two
students completed both the gender and intent to vaccinate question. Fifty-two students
were male, and one-hundred students were female. Twenty-one males (40.4%) intended
to receive the HPV vaccine while, twenty-five females (25%) stated they intended to
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receive the vaccine. Overall, only forty-six (30.3%) of the students reported that they
would receive the vaccine. When comparing gender in relation to Black college students’
intention to vaccinate, there was a significant association between gender and intent to
receive the vaccine (p=0.050) (See Table 5), with Black male college students indicating
more frequently than Black female students an intent to vaccinate for HPV.
Table 5
Gender Chi-Square Tests
Asymptotic
Significanc

Exact Sig.

Exact Sig.

Point
Probability

Value

df

e (2-sided)

(2-sided)

(1-sided)

Pearson Chi-Square

3.837

a

1

.050

.063

.039

Continuity

3.142

1

.076

3.756

1

.053

.063

.039

.063

.039

.063

.039

Correction

b

Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear

3.811

c

1

.051

.022

Association
N of Valid Cases

152

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.74.
b. Computed only for a 2x2 table
c. The standardized statistic is -1.952.

Rural versus Urban Geographic Location Chi-square
A chi-square goodness of fit test for homogeneity was calculated comparing
location and Black college students’ intent to receive the HPV vaccination. The number
of participants responding to this item was one-hundred and fifty-two students (n=152).
One-hundred and sixteen students (76.3%) were from an urban area, while thirty-six
(23.7%) were from a rural area. Forty-seven (30.9. %) students intended to receive the
vaccine. When comparing location and Black college students’ intention to vaccinate, no
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significant difference was found for urban versus rural geographic location in relation to
Black college students’ intent to receive the HPV vaccination although the probability
was close to significance at .055. (See Table 6).
Table 6
Rural versus Urban Geographic Location Chi-Square Tests
Asymptotic
Significanc Exact Sig.

Exact Sig.

Point

(1-sided)

Probability

.218

.055

Value

df

e (2-sided)

(2-sided)

Pearson Chi-Square

2.505

a

3

.474

.483

Likelihood Ratio

2.618

3

.454

.474

Fisher's Exact Test

2.450

Linear-by-Linear

.791

b

.488
1

.374

.426

Association
N of Valid Cases

152

a. 2 cells (25.0%) have expected count less than 5. The minimum expected count is 2.47.
b. The standardized statistic is .889.

Summary of Findings for Question 1
More than two-thirds (69.7%) of the sample had no intention to vaccinate for
HPV. Overall, only forty-six (30.3%) of the students reported that they would receive the
vaccine. A significant difference was not found for age and intent to vaccinate in Black
college students, t (151) =1.54, p=0.125, d=0.245. When comparing gender and Black
college students’ intention to vaccinate, an association was found between gender and
intent to vaccinate (p=0.050). Therefore, there was an association between gender and
Black college student’ intentions to vaccinate with Black males more likely to note an
intent to vaccinate than Black females. When considering rural versus urban geographic
location, forty-seven (30.9. %) students intended to receive the vaccine. However, no
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significant association was found for urban versus rural location for Black college
students’ intent to receive the HPV vaccination.
Research Question 2
Question: What are the relative contributions of perceived vulnerability, perceived
severity, perceived benefits, and perceived barriers to HPV vaccination intention among
male and female Black college students?
Hypothesis: Higher perceived vulnerability, perceived severity and perceived benefits
scores, and lower perceived barriers scores will be associated with increased intentions to
receive vaccination in Black college students who intend to vaccinate.
Measurement Instrument
The student human papillomavirus survey (SHPVS) is a 27-item measure of
students’ perceived benefits/barriers to HPV vaccination (Thomas, Dalmida, & Higgins,
2016). This instrument measured the perceived vulnerability, severity, benefits, and
barriers for this study. This 27-item questionnaire was scored using a 5-choice Likert
scale, ranging from 1= disagree to 5 = agree. When the scores are tabulated, they can
range from 0-108; with higher scores equating to more knowledge and increased
intentions to be vaccinated with the HPV vaccine (Thomas, Dalmida, & Higgins, 2016).
Higher scores indicate that the participants had higher perceived benefits, vulnerability,
severity, have more positive attitudes toward vaccination while high barriers scores
reflect more negative attitudes related to HPV vaccine (Thomas, Dalmida, & Higgins,
2016). For the participants in this study (n=160) scores ranged from 42 to 104, and the
mean total score for the SHPVS tool was 75.1, sd=9.86. The subscales were tabulated as
follows: perceived vulnerability (questions: 5-9, 11, and 25; a total of 7 questions),
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severity (questions 10, 12-13, 15-16, and 21; a total of 6 questions), benefits (questions 14, 14, 17-20; a total of 9 questions,) and barriers (questions 22-24, 27, and 26; a total of 5
questions). The scores of these subscales were used as the data for the independent
variables in the individual analysis.
Statistical Test
Since the research questions seek to determine if there are relative contributions
of perceived vulnerability, perceived severity, perceived benefits, and perceived barriers
to HPV vaccination intention among male and female Black college students; the
binomial logistic regression was used to complete the analysis of the data. The
independent variable is ordinal/categorical, and the dependent variable is dichotomous.
This type of analysis allowed the researcher to use interactions between independent
variables to predict the dependent variable.
Research Question 2 Results
Perceived Vulnerability
A binomial logistic regression analysis was conducted to determine if perceived
vulnerability made a contribution on HPV vaccinations intentions in male and female
Black college students. The casewise diagnostic table was reviewed and there were no
outliers, thus analysis of the results was conducted without any value being removed.
First, the data coding was reviewed to ensure that the analysis was run appropriately and
that there were enough cases. There were 160 eligible cases, however there were missing
data and 8 cases were omitted from the analysis, so the total number of cases analyzed
was 152. There were 52 male and 100 female participants for this analysis. The model fit
was not significant (p=0.523) for the overall statistical significance of the model, thus the
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model is not a poor fit. The percentage accuracy in classification (PAC) is 69.7%. This
means that adding the perceived vulnerability (independent variable) improved the
overall prediction of cases.
The casewise diagnostic table was reviewed and there were no outliers, thus
analysis of the results was conducted without any value being removed. The logistic
regression model was not statistically significant, χ2(3) = 5.193, p=0.158. The model
explained 4.8% (Nagelkerke R2) of the variance in intent to receive the HPV vaccination
and correctly classified 69.7% of cases. Sensitivity was 0%, specificity was 100%,
positive predictive value was 0% and negative predictive value was 69.74%. Of the two
predictor variables only one approached statistical significance: gender (p=.059) (as
shown in Table 7). Females had 0.50 times less likely the odds to plan to receive the
vaccination than males. There was no significant interaction between perceived
vulnerability and gender, in reference to their intent to receive the HPV vaccination
(p=0.294) (Table 8).

Table 7
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on
Gender and Perceived Vulnerability
95% C.I.for
Exp(B

EXP(B)
Lower Upper

B

S.E.

Wald

df

Sig.

)

Step

Gender

-.693

.366

3.576

1

.059

.500

.244

1.026

1a

Perceived

-.021

.037

.324

1

.569

.979

.910

1.053

.056

.830

.005

1

.946

1.058

Vulnerability
Total Score
Constant

Note: Gender is for female compared to male.

76

Table 8
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender by
Perceived Vulnerability Interaction Term
95% C.I.for

Step
1

a

Exp(B

EXP(B)
Lower Upper

B

S.E.

Wald

df

Sig.

)

Gender

.979

1.632

.360

1

.549

2.662

.109

65.254

Perceived

.019

.053

.129

1

.720

1.019

.919

1.131

-.078

.075

1.101

1

.294

.925

.799

1.070

-.793

1.163

.466

1

.495

.452

Vulnerability
Total Score
Interaction Term:
Gender by
Perceived
Vulnerability
Total Score
Constant

Note: Gender is for female compared to male.

Perceived Severity
A binomial logistic regression analysis was conducted to determine if perceived
severity made a contribution to HPV vaccinations intentions in male and female Black
college students. There were 160 eligible cases for analysis; however, there were missing
data and 8 cases were omitted from the analysis. Therefore, the total number of cases
analyzed was 152. There were 52 male and 100 female participants cases. The model fit
was not significant (p=0.728) for the overall statistical significance of the model, thus the
model is not a poor fit. The percentage accuracy in classification (PAC) was 72.4%. This
means that adding the perceived severity (independent variable) improved the overall
prediction of cases.
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The binomial logistic regression model was statistically significant, χ2(3) = 9.692,
p=0.021. The model explained 8.7% (Nagelkerke R2) of the variance for intent to receive
the HPV vaccination, and it correctly classified 69.7% of cases.
Sensitivity was 0%, specificity was 100%, positive predictive value was 66.7%
and negative predictive value was 72.85%. Of the three predictor variables one was
statistically significant total scores for the severity scale (p=0.032) (as shown in Table 9);
while the and the interaction variable between perceived severity and intent to vaccinate
approached significance (p=0.061). Perceived severity had 1.256 more likely times odds
to intend to vaccinate, while the interaction variable had 1.012 times odds to intend to
receive vaccination. Gender was not a significant predictor for perceived severity.
Although total scores on the severity scale was a significant predictor, severity scores
also significantly interacted with intent to receive HPV vaccination indicating intent and
severity were associated.
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Table 9
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender by
Perceived Severity Interaction Term
95% C.I.for
Exp(B
Step

Gender

EXP(B)

B

S.E.

Wald

df

Sig.

)

Lower

Upper

3.886

2.451

2.515

1

.113

48.732

.400

5941.7

1a

27
Perceived Severity

.228

.106

4.588

1

.032

1.256

1.020

1.547

-.259

.138

3.515

1

.061

.772

.589

1.012

-4.468

1.953

5.232

1

.022

.011

Total Score
Gender by
Perceived Severity
Total Score
Constant

Note: Gender is for female compared to male.

Perceived Benefits
A binomial logistic regression analysis was conducted to determine if perceived
benefits made a contribution on HPV vaccinations intentions in male and female Black
college students. The casewise diagnostic table was reviewed and there were no outliers,
thus analysis of the results was conducted without any value being removed. The data
coding was reviewed to ensure that the analysis was run appropriately and that there were
enough cases. There were 160 eligible cases, and 8 cases with missing data were omitted
from the analysis. Hence, the total number of cases analyzed was 152. Data for 52 male
and 100 female participants were entered into the model. The model fit was not
significant (p=0.909) for the overall statistical significance of the model, thus the model
was not a poor fit. The percentage accuracy in classification (PAC) is 69.1%. This means
that adding the perceived benefit (independent variable) improved the overall prediction
of cases.
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The binomial logistic regression model was statistically significant, χ2(2) = 6.460,
p=0.040. The model explained 55.9% (Nagelkerke R2) of the variance in intent to receive
the HPV vaccination and correctly classified 69.7% of cases. Sensitivity was 2.2%,
specificity was 98.1%, positive predictive value was 33.3% and negative predictive value
was 95.41%. Of the two predictor variables only one was statistically significant: gender
(p=.041) (as shown in Table 10). Females had 0.468 times lower the odds to plan to
receive the vaccination than males. There was no significant interaction between
perceived benefits and gender, in reference to their intent to receive the HPV vaccination
(p=0.224) (See Table 11). Therefore, females were less likely than males to intend to
receive HPV vaccination based on perceived benefits. However, in general perceived
benefits did not play a significant role in intent to receive HPV vaccination.
Table 10
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender
and Perceived Benefit
95% C.I.for

Step
1

a

Exp(B

EXP(B)
Lower Upper

B

S.E.

Wald

df

Sig.

)

GENDER

-.759

.371

4.192

1

.041

.468

.226

.968

Perceived

-.070

.043

2.644

1

.104

.932

.857

1.015

1.187

1.009

1.384

1

.239

3.277

Benefit

Total

Score
Constant

Note: Gender is for female compared to male.
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Table 11
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Interaction of
Gender and Perceived Benefit
95% C.I.for
EXP(B)

Step
1

a

B

S.E.

Wald

df

Sig.

Exp(B)

Lower

Upper

1.565

1.941

.650

1

.420

4.782

.106

214.781

Score -.011

.064

.031

1

.861

.989

.872

1.121

-.106

.087

1.481

1

.224

.900

.759

1.067

-.137

1.473

.009

1

.926

.872

Gender
Total

Perceived Benefit
Gender by Total
Score

Perceived

Benefit
Constant

Note: Gender is for female compared to male.

Perceived Barriers
With the interaction term. A binomial logistic regression analysis was conducted to
determine if perceived barriers made a contribution on HPV vaccinations intentions in
male and female Black college students. The casewise diagnostic table was reviewed and
there was one outlier, the standardized residual had a value of -2.230, thus analysis of the
results was conducted without any value being removed.
Of the 160 eligible cases, the total number of cases available for analysis was 152
due to missing data. There were 52 male and 100 female participants in this analysis. The
model fit was not significant (p=0.096) for the overall statistical significance of the
model, thus the model was not a poor fit. The percentage accuracy in classification (PAC)
was 73.7%. This means that adding the perceived barriers (independent variable)
improved the overall prediction of cases.
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The binomial logistic regression model was statistically significant, χ2(3) =
12.008, p=0.007. The model explained 10.8% (Nagelkerke R2) of the variance in intent
to receive the HPV vaccination and correctly classified 73.7% of cases. Sensitivity was
21.7%, specificity was 96.2%, positive predictive value was 71.43% and negative
predictive value was 73.91%. Of the three predictor variables one was statistically
significant, perceived barriers (p=0.018) (as shown in Table 12). Perceived barriers had
0.80 times lower the odds to explain intent to receive the vaccination. There was no
significant interaction between perceived barriers and gender, in reference to participants’
intent to receive the HPV vaccination (p=0.266) (Table 12). Therefore, perceived barriers
was a significantly predictor of intent to receive vaccination regardless of gender.
Table 12
Logistic Regression Predicting Likelihood of HPV Vaccination Intention HPV Vaccination
Intention Based on Interaction of Gender and Perceived Barrier
95% C.I.for
EXP(B)
Step
1

a

B

S.E.

Wald

df

Sig.

-2.505

1.518

2.725

1

.099

.082

.004

1.599

Barrier

-.224

.094

5.597

1

.018

.800

.665

.962

by

.131

.118

1.235

1

.266

1.140

.905

1.436

2.498

1.260

3.930

1

.047

12.155

Gender
Perceived

Exp(B) Lower

Upper

Total Score
Gender
Perceived

Barrier

Total Score
Constant

Note: Gender is for female compared to male.

When the interaction variable is not considered. When not considering the
interaction of gender and perceived barriers, the model fit was not significant (p=0.116)
for the overall statistical significance of the model, thus the model is not a poor fit. The
percentage accuracy in classification (PAC) was 73.0%. This means that adding the
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perceived barriers (independent variable) improved the overall prediction of cases. The
binomial logistic regression model was statistically significant, χ2(2) = 10.727, p=0.005.
The model explained 9.6% (Nagelkerke R2) of the variance in intent to receive the HPV
vaccination and correctly classified 73.0% of cases. Sensitivity was 17.4%, specificity
was 97.2%, positive predictive value was 72.73% and negative predictive value was
73.05%. Of the two predictor variables both were statistically significant, gender
(p=0.021) and perceived barriers (p=0.010) (as shown in Table 13). For gender females
had 0.411 times less likely the odds than males to plan to receive the vaccination. For
perceived barriers, participants had 0.867 times lower the odds to plan to receive the
vaccination. There was no significant interaction between perceived barriers and gender,
in reference to their intent to receive the HPV vaccination (p=0.266).
Table 13
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender and
Perceived Barrier
95% C.I.for
EXP(B)

Ste
p1

a

GENDER
Perceived

Barrier

B

S.E.

Wald

df

Sig.

Exp(B) Lower

Upper

-.889

.384

5.346

1

.021

.411

.194

.873

-.143

.055

6.638

1

.010

.867

.777

.966

1.458

.772

3.567

1

.059

4.297

Total Score
Constant

Note: Gender is for female compared to male.

Summary of Question 2 Results
Binomial logistic regressions were performed to ascertain the effects of perceived
vulnerability, severity, benefits, and barriers on HPV vaccinations intentions in male and
female Black college students. The hypothesis that guided this question was that: higher
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perceived vulnerability, perceived severity and perceived benefits scores, and lower
perceived barriers scores will increase intentions to receive vaccination in Black college
students who intend to vaccinate. Gender was not a significant predictor of intent to
vaccinate based on perceived vulnerability, perceived severity, and perceived barriers.
However, females were less likely than males to intend to receive HPV vaccination based
on perceived benefits. Total scores on the severity scale was a significant predictor of
intent to vaccinate, but severity scores also significantly interacted with intent to receive
HPV vaccination indicating intent and severity were associated. Perceived benefits of
receiving HPV vaccination was not significant in predicting intent to receive HPV
vaccination. Perceived barriers was a significantly predictor of intent to receive HPV
vaccination regardless of gender. There was no significant interaction between perceived
vulnerability and gender, in reference to participants’ intent to receive the HPV
vaccination (p=0.294). The interaction between perceived severity and gender, in
reference to intent to receive the HPV vaccination approached significance (p=0.061).
There was no significant interaction between perceived benefits and gender, in reference
to participants’ intent to receive the HPV vaccination (p=0.224). There was no significant
interaction between perceived barriers and gender, in reference to intent to receive the
HPV vaccination (p=0.266). Results for the hypothesis were mixed with some results
supporting the hypothesis and other results not supporting the hypothesis.
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Research Question 3
Question: What are the relative contributions of trust/mistrust, social influence,
and prior sexual behavior to HPV vaccination intention among male and female Black
college students?
Hypothesis: Trust, social influence, and prior sexual behavior will have a positive effect
on intent of Black college students to receive the HPV vaccination.
Research Question 3 Results
Trust/Mistrust Instrument
To measure the variable trust/mistrust the Health Care System Distrust Scale
(HCSDS) was utilized. This 10-item scale is scored on a 5-point Likert scale (Rose,
Peters, Shea, & Armstrong, 2004). The total score for the instrument ranges from 10 to
50, with higher scores meaning more distrust. For the participants in this study the
minimum score was 13, the maximum score was 49, and the mean score was 30.6,
sd=5.36. The median score of participants in this study suggested that they had a
moderate level of distrust. The data from this instrument were tabulated and used in the
analysis of Research Question 3.
Trust/Mistrust
A binomial logistic regression analysis was conducted to determine if
trust/mistrust made a contribution on HPV vaccinations intentions in male and female
Black college students. The casewise diagnostic table was reviewed and there were no
outliers, thus analysis of the results was conducted without any value removed.
First, data coding was reviewed to ensure that the analysis was run appropriately and that
there were enough cases. There were 160 eligible cases, however some data were
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missing, and 10 cases were omitted from the analysis, so the total number of cases
analyzed was 150. There were 51 male and 99 female participants in this analysis. The
model fit was not significant (p=0.557) for the overall statistical significance of the
model, thus the model is not a poor fit. The percentage accuracy in classification (PAC)
was 68.7%. This means that adding the trust/mistrust (independent variable) improved
the overall prediction of cases.
The binomial logistic regression model approached statistical significance, χ2(2)
= 5.821, p=0.054. The model explained 5.4% (Nagelkerke R2) of the variance of intent to
receive the HPV vaccination and correctly classified 68.7% of cases. Sensitivity was 0%,
specificity was 99%, positive predictive value was 0% and negative predictive value was
69.13%. Of the two predictor variables only one was statistically significant: gender
(p=.033) (as shown in Table 14). Females had 0.45 times less likely the odds to plan to
receive the vaccination than males and were less likely to intend to receive HPV
vaccination based on trust/mistrust. There was no significant interaction between
trust/mistrust and gender, in reference to their intent to receive the HPV vaccination
(p=0.771) (Table 15).
Table 14
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender and
Trust/Mistrust
95% C.I.for
EXP(B)
Step
1

a

B

S.E.

Wald

df

Sig.

Exp(B) Lower

Gender

-.799

.374

4.569

1

.033

.450

.216

.936

Trust/Mistrust

-.047

.035

1.843

1

.175

.954

.892

1.021

1.118

1.118

.998

1

.318

3.057

Total Score
Constant

Note: Gender is for female compared to male.
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Upper

Table 15
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender by
Trust/Mistrust Interaction Term
95% C.I.for
Exp(B
Step
1

a

EXP(B)

B

S.E.

Wald

df

Sig.

)

Lower

Upper

Gender

-.153

2.249

.005

1

.946

.858

.010

70.458

Trust/Mistrust

-.033

.058

.326

1

.568

.967

.863

1.084

-.021

.072

.085

1

.771

.979

.850

1.128

.688

1.845

.139

1

.709

1.989

Total Score
Gender

by

Trust/Mistrust
Total Score
Constant

Note: Gender is for female compared to male.

Social Influence
Health Behavior Instrument
The Perceived Social Influence on Health Behavior Instrument (PSI-HB)
instrument was used to measure social influence in this study. This scale has 10 items that
are scored using a 4-point Likert scale (Holt et al., 2010). The total score could range
from 10-40, with higher scores being indicative of higher levels of belief that others
effect an individual’s health behavior (Holt et al., 2010). For the participants in this study
the minimum score was 10, maximum score 38, and mean score of 21.2, sd=21.22=. This
means that the average score for participants in this study suggest that they had a
moderate belief that others effect an individuals’ health behavior. The results of total
scores for the instrument were tabulated and used in the analysis. A binomial logistic
regression analysis was conducted to determine the if perceived social influence made a
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contribution on HPV vaccinations intentions in male and female Black college students.
The casewise diagnostic table was reviewed and there were no outliers, thus analysis of
the results was conducted without any value being removed.
First, the data coding was reviewed to ensure that the analysis was run appropriately and
that there were enough cases. There were 160 eligible cases, however some were missing
data and 10 cases were omitted from the analysis, so the total number of cases analyzed
was 150. There were 50 and 100 female participants. The model fit was not significant
(p=0.460) for the overall statistical significance of the model, thus the model is not a poor
fit. The percentage accuracy in classification (PAC) is 70.7%. This means that adding the
social influence (independent variable) improved the overall prediction of cases.
The binomial logistic regression model was not statistically significant, χ2(3) =4.066,
p=0.254.
The model explained 3.8% (Nagelkerke R2) of the variance in intent to receive
the HPV vaccination and correctly classified 70.7% of cases.
Sensitivity was 2.2%, specificity was 100%, positive predictive value was 100% and
negative predictive value was 70.5%. Of the two predictor variables none were
statistically significant. There was no significant interaction between social influence and
gender, in reference to their intent to receive the HPV vaccination (p=0.665) (Table 16).
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Table 16
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender by
Social Influence Interaction Term
Step 1

a

B

S.E.

Wald

df

Sig.

Exp(B)

-.020

1.499

.000

1

.989

.980

Social

.037

.051

.522

1

.470

1.038

Gender by Total Score

-.029

.066

.187

1

.665

.972

-1.253

1.215

1.064

1

.302

.286

Gender
Total

Score

Influence
Social Influence
Constant

Note: Gender is for female compared to male.

Prior Sexual Behavior
Sexual Risk Survey (SRS) and Sexual Experience Questionnaire
The sexual risk survey (SRS) and sexual experience questionnaire was used to
measure the prior sexual behavior variable. The SRS has 23 items that was designed to
assess risky sexual behaviors that individuals have participated in within the past six
months prior to completing the survey (Turchik & Garske, 2009). The items are scored
on a scale from 0-4 and the possible total score range for the instrument is 0-92 (Turchik,
Walsh, & Marcus, 2015). When the survey score is tabulated, higher scores indicate
greater sexual risk-taking behavior. For the participants in this study the minimum score
was 0, maximum score 47, and the mean score was 7.8, sd=7.98. For this group of
participants, the score suggested that they have low sexual risk-taking behavior. The
sexual experience questionnaire has seven questions, of which five elicit “yes/no”
answers, one elicits data regarding sexual practices, and one elicits data regarding sexual
partners. The “yes” answers were scored as 2, while the “no” answers were scored as 1;
for question number 3, the choices were scored as never=1, protect=2, unprotected=3;
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and for question 6 the choices were scored as none=0, 1 person=1, 2 people=2, 3
people=3, and 4 or more as 4. The scores could range from 6-16; higher scores indicated
more sexual experience. For the participants in this study the minimum score was 2,
maximum score 16, and mean score of 10.4, sd=2.87. For this group of participants, the
score suggest that they have a moderate amount of sexual experience. The scores from
each individual instrument were tabulated, and then combined to use as the variable in
the analysis.
A binomial logistic regression analysis was conducted to determine if prior sexual
behavior made a contribution to HPV vaccinations intentions in male and female Black
college students. The casewise diagnostic table was reviewed and there were no outliers,
thus analysis of the results was conducted without any value being removed.
First, the data coding was reviewed to ensure that the analysis was run
appropriately and that there were enough cases. Of the160 eligible cases, 9 cases were
omitted from the analysis due to missing data, so the total number of cases analyzed was
151. There were 51 male and 100 female participants that remained in the analysis. The
model fit was not significant (p=0.551) for the overall statistical significance of the
model, thus the model is not a poor fit. The percentage accuracy in classification (PAC)
was 69.5%. This means that adding the prior sexual behavior (independent variable)
improved the overall prediction of cases.
The binomial logistic regression model was not statistically significant, χ2(2) =
4.631, p=0.099. The model explained 4.3% (Nagelkerke R2) of the variance in intent to
receive the HPV vaccination and correctly classified 69.5% of cases. Sensitivity was 0%,
specificity was 100%, positive predictive value was 0% and negative predictive value
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was 69.54%. Of the two predictor variables only one was statistically significant: gender
(p=.032) as shown in Table 17. Female participants had 0.437 times less likely the odds
to plan to receive the vaccination than males. Therefore, females were less likely to
intend to receive HPV vaccination than males in the analysis of sexual behavior scores.
The total prior sexual behavior score was not significant, which indicated no contribution
of prior sexual behavior on intent to receive HPV vaccination. There was no significant
interaction between prior sexual behavior and gender, in reference to participants’ intent
to receive the HPV vaccination (p=0.704) (Table 18).
Table 17
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender and
Prior Sexual Behavior
95% C.I.for
EXP(B)

Step
1

a

B

S.E.

Wald

df

Sig.

Exp(B) Lower

Gender

-.828

.386

4.611

1

.032

.437

.205

.930

Total Score

-.013

.018

.543

1

.461

.987

.952

1.023

-.057

.494

.013

1

.909

.945

Prior Sex
Constant

Note: Gender is for female compared to male.
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Upper

Table 18
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender by
Prior Sexual Behavior Interaction Term
95% C.I.for

Step
1

a

Exp(B

EXP(B)
Lower Upper

B

S.E.

Wald

df

Sig.

)

Gender

-.570

.779

.536

1

.464

.565

.123

2.601

Total Prior Sex

-.008

.024

.108

1

.743

.992

.947

1.039

Gender by Total

-.014

.037

.145

1

.704

.986

.916

1.061

-.184

.596

.095

1

.758

.832

Prior Sex
Constant

Note: Gender is for female compared to male.

Summary for Question 3 Results
Binomial logistic regressions were performed to determine if trust/mistrust, social
influence, and prior sexual behavior predicted HPV vaccinations intentions in male and
female Black college students. In each analysis, the hypothesis was rejected;
trust/mistrust, social influence, and prior sexual behavior did not have a positive effect on
intent of Black college students to receive the HPV vaccination. However, gender had a
significant relationship in determining if trust/mistrust and prior sexual behavior
predicted HPV vaccination intentions in male and female Black college students. Female
gender had lower odds of predicting intent to receive HPV vaccination than male gender
for trust/mistrust and prior sexual behavior, indicating that females were less likely to
intend to receive HPV vaccination based on trust/mistrust and prior sexual behavior
scores.
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Research Question 4
Question: Has the new practice recommendation to change the HPV vaccination series
from a 3-dose to a 2-dose series for male and females caused a difference in intent to
vaccinate for Black college students?
Hypothesis: The decrease in the vaccine series dosing from 3 doses to 2 doses will have a
negative effect on Black college student’s intentions to vaccinate. Gender will play a role
in the decision to vaccinate based on the change in HPV Vaccination policy for the
number of doses for young adolescents.
Student Human Papillomavirus Survey Instrument
The student human papillomavirus survey (SHPVS) is a 27-item instrument
designed to review students’ perceived benefits/barriers to HPV vaccination (Thomas,
Dalmida, & Higgins, 2016). One question was added to the end of this survey to solicit
data regarding the intention to receive vaccination now that the dose recommendation for
the vaccine series had been modified from 3 doses to 2 doses. The 28-item instrument
was scored using a 5 choice Likert scale. The score was tabulated from this question
(number 28) and utilized in the regression model.
Research Question 4 Results
A binomial logistic regression analysis was conducted to determine if a change in
dosing made a contribution to HPV vaccinations intentions in male and female Black
college students. There were two standardized residuals with a value of 3.062 and 3.062
respectively, which were kept in the analysis.
First, the data coding was reviewed to ensure that the analysis was run
appropriately and that there were enough cases. There were 160 eligible cases, however
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some were missing data and 10 cases were omitted from the analysis, so the total number
of cases analyzed was 150. There were 51 male and 99 female participants. The model fit
was not significant (p=0.621) for the overall statistical significance of the model, thus the
model is not a poor fit. The percentage accuracy in classification (PAC) is 70.0%. This
means that adding the change in dosing from 3 doses to 2 doses (independent variable)
improved the overall prediction of cases.
The binomial logistic regression model was statistically significant, χ2(2) =
12.404, p=0.002. The model explained 11.2% (Nagelkerke R2) of the variance in intent
to receive the HPV vaccination and correctly classified 70.0% of cases. Sensitivity was
19.6%, specificity was 92.3%, positive predictive value was 52.94% and negative
predictive value was 72.18%. Of the two predictor variables only one was statistically
significant: Black college students will become more likely to be vaccinated since the
dosing has changed from 3 doses to 2 doses (p=.006) (as shown in Table 19). The
participants had 1.789 times more likely the odds to plan to receive the vaccination.
There was no significant interaction between change in dosing and gender, in reference to
their intent to receive the HPV vaccination (p=0.631) (Table 20).
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Table 19
Logistic Regression Predicting Likelihood of HPV Vaccination Intention HPV Based on
Gender and Change in Dosing
95% C.I.for
EXP(B)

Step
1

a

B

S.E.

Wald

df

Sig.

Exp(B) Lower Upper

Gender

-.578

.381

2.305

1

.129

.561

.266

1.183

Change in

.582

.211

7.571

1

.006

1.789

1.182

2.707

-2.242

.752

8.881

1

.003

.106

Dosing
Constant

Note: Gender is for female compared to male.

Table 20
Logistic Regression Predicting Likelihood of HPV Vaccination Intention Based on Gender
by Change in Dosing Interaction Term
95% C.I.for
EXP(B)
Step
1

Gender

B

S.E.

Wald

df

Sig.

.085

1.434

.004

1

.952

Exp(B) Lower Upper
1.089

.066

a

18.11
3

Total Score

.702

.335

4.388

1

.036

2.018

1.046

3.893

-.208

.433

.231

1

.631

.812

.347

1.899

-2.637 1.138

5.363

1

.021

.072

Change in Dosing
Gender by Total
Score Change in
Dosing
Constant

Note: Gender is for female compared to male.

Summary of Research Questions
The research was conducted in pursuit of four aims. For aim one it was found
that: for age there was not a statistical difference in age and intent to vaccinate in Black
college students, nor was there a difference in the mean age of individuals that intended
to vaccinate and those that did not. Gender influenced Black college students’ intention to
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vaccinate with males intending to vaccinate more than females; but location of college
attendance did not have a statistical significance on Black college students’ intention to
vaccinate. For aim two: For perceived vulnerability gender approached significance, with
females being less likely to receive vaccination based on perceived vulnerability. For
Perceived severity the total scores had a statistical significance, which indicated a higher
likelihood to vaccinate. For perceived benefits, gender had statistical significance, with
females being less likely than males to receive vaccination. For perceived barriers total
scores significantly indicated a less likely hood to receive the vaccination; the greater the
score, the more likely the participants were not to receive vaccination. For aim three
there was no relative contributions of trust/mistrust, social influence, or prior sexual
behavior on intent to vaccinate. Although, gender had a statistical significance, in
trust/mistrust and prior sexual behavior, female participants were less likely to plan to
receive the vaccination than males. For aim four, there is a statistical difference noted
regarding the change in dosing from three to two doses; Black college students were
more likely to intend to become vaccinated. However, it was noted that of the sample of
157 students, 101 of the student participants expressed that they were “unsure” if they
would receive the vaccination due to a change in dosing.
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Chapter 5: Discussion
Background
Research has shown that parents in the United States have concerns regarding
vaccinations in general, and particularly the HPV vaccine. Therefore, many young men
and women entering college have not received the HPV vaccination. College students can
receive health care, such as vaccinations, without the necessity of parental consent.
However, studies have shown that college students may not even be aware that there is an
HPV vaccine, and that they should get vaccinated.
A finding from the review of the literature was that the type of institution where
the students studied at, positivielly correlated with vaccine uptake (Lee, Lust, Vang, and
Desai, 2018). Another finding was that research that explores gender and racial diversity
is warranted in future studies involving HPV. Additionally, several studies found that
there is a clear distinction for health outcomes for individuals living in rural areas. Many
Black Americans live in the Southern areas of the United States. Thomas, DiClemente,
and Snell (2014) noted that to develop impartial and beneficial health promotion
programs, geographic factors must be taken into consideration.
Purpose of Study
This research study was conducted to determine HPV vaccine intentions in
vaccine naïve young Black college students. The study used a non-experimental cross
sectional research design. The study addressed four research questions:
1. Is there a difference in demographics (age, gender, geographic location) between
Black college students who intend to receive the HPV vaccine and those who do
not intend to receive the vaccination?

97

2. What are the relative contributions of perceived vulnerability, perceived severity,
perceived benefits, and perceived barriers to HPV vaccination intention among
male and female Black college students?
3. What are the relative contributions of trust/mistrust, social influence, and prior
sexual behavior to HPV vaccination intention among male and female Black
college students?
4. Has the new practice recommendation to change the HPV vaccination series from
a 3-dose to a 2-dose series for young girls caused a difference in intent to
vaccinate for college students, and is there a difference between male and female
Black college students?
Methodology
Prior to the start of data collection, IRB approval was received from FIU, MDC,
TU and FMU. This descriptive study was conducted to determine HPV vaccine
intentions in vaccine naïve young Black college students. There was one demographic
instrument and four survey questionnaires used in this study. The instruments were
combined into a single packet. The surveys used for this study were the Sexual Risk
Survey (SRS), Sexual Experience Questionnaire, the Student Human Papillomavirus
Survey (SHPVS), the Perceived Social Influence on Health Behavior Instrument (PSIHB), and the Health Care System Distrust Scale (HCSDS). The convenience sample of
male and female students, age 18-24, were recruited from two minority serving
institutions (MSIs) of higher education in the southeastern area of the United States,
Miami Dade College (MDC) and Florida International University (FIU); and two
historically Black colleges and universities (HBCUs), also in the southeastern area of the
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United States, Tuskegee University (TU) and Florida Memorial University (FMU).
Students were recruited from the four sites. Participants received a survey packet and
completed the self-administered questionnaire. As an incentive for participation, after
turning in a completed packet, the student received a $5 gift.
Data from the demographic instrument was analyzed using descriptive data
analysis procedures. The scores from the different surveys were tabulated and used to run
data analysis. The data analysis for question 1 was done with independent t-tests and chisquare goodness of fit test for homogeneity. The data analysis for questions 2 thru 4 were
completed with binomial logistical regressions.
Summary of Findings
Question 1
Age. The research question sought to find out if there was a difference in demographics
(age, gender, geographic location) between Black college students who intend to receive
the HPV vaccine and those who do not intend to receive the vaccination. The mean age
of participants in this study was 21. The analysis of this data found that there was not a
statistical difference in age and intent to vaccinate in Black college students, nor was
there a difference in the mean age of individuals that intended to vaccinate and those that
did not. In several studies, it was found that younger women were more likely to receive
the vaccination (Manhart et al., 2011; Marchand, Glenn, and Bastani, 2012; Wilson et al.,
2017). Similarly, college women age 18-25 were likely to already have received the
vaccine (Wolwa et al., 2013). In this study the results were not significant but, this does
not negate the data gathered in other studies. Age alone, cannot be a reliable indicator of
Black college students’ intentions to vaccinate.
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Gender. The research question sought to find out if there was a difference in
gender, between Black college students who intend to receive the HPV vaccine and those
who do not intend to receive the vaccination. There were more females (100, n=152) in
this study than males (52, n=152). The data from this analysis noted that gender could
influence Black college students’ intention to vaccinate. As shown in the chapter, 40.4%
(n=52) of males and 25% (n=100) of female participants confirmed that they would
receive the HPV vaccination. Since there are 290 million women infected with HPV
worldwide, gender should not be overlooked when assessing vaccination intentions
(WHO, 2016). Koplas, Braswell, and Smalls (2019) found that females had a higher
vaccine uptake in comparison to males, while Fontenot et al. (2014) found that 74%
(n=735) of the college male students had not received HPV vaccination. Cooper et al.,
2018 conducted a study and found that 71.1% of the male participants did not intend to
receive the HPV vaccine. Darensbourg et al., (2019) also found that 68% of the female
participants intended to be vaccinated with HPV.
Rural versus Urban Geographic Location. The research question sought to find
out if there was a difference in demographics geographic location between Black college
students who intend to receive the HPV vaccine and those who do not intend to receive
the vaccination. The research in this study did not have a statistical significance in
location (rural versus urban) and Black college students’ intention to vaccinate (p=0.474).
Although, the participants in the urban area intended to receive the vaccine more than
those attending college in a rural area. In one study it was found that a lower vaccine rate
was seen in patients 18-26 in an urban hospital (Schluterman, Terplan, and Lydecker,
2011). While, Thomas, Caldera, and Maureer (2109) found that rural communities need
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to focus on cultural norms when providing HPV vaccine knowledge and this will
decrease HPV vaccine hesitancy. Although this research suggested that location of
participants did not contribute to the decision to receive vaccination, it is imperative to
note that another study found that to reduce the incidence of mortality from HPV related
cancers, vaccine access in rural communities should be increased (Vanderpool,
Stradtman, and Brandt, 2019).
Question 2
Perceived Vulnerability. The research question sought to find out if there were
any relative contributions from perceived vulnerability to HPV vaccination intentions
among male and female Black college students. This research found that there was not a
significant interaction between perceived vulnerability and gender, in reference to their
intent to receive the HPV vaccination. However, female participants had a 0.50 time less
likelihood to plan to receive the vaccination than males. HPV is a sexually transmitted
disease; thus, unprotected sex makes a person vulnerable to HPV. However, a study
conducted by Fontenot et al., (2014) with male participants found that although males
were sexually active with low condom usage, 93% (n=735) reported that they were not at
risk for STIs. In a study conducted by Patel and colleagues (2012), in female students, it
was found that at baseline 41% of the participants intended to receive the HPV
vaccination; unlike this study. Bendik, Mayo, & Parker, (2011) found that the female
participants in their study had received the vaccine if they perceived that they might get
cervical cancer. This data is again contrary to what this study found. However, Bynum et
al., (2011) found similar results to what was found in this study and noted that
susceptibility to HPV was not a predictive factor for vaccine uptake.
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Perceived severity. The research question sought to find out if there were any
relative contributions from perceived severity to HPV vaccination intentions among male
and female Black college students. This study found that the results for the total score
was statically significance while the interaction variable between perceived severity and
intent to vaccinate only approached significance. Similarly, Fontenot et al., (2014)
conducted a study in college males and found that they had low perceived severity of
HPV, and that there was an actual risk of contracting HPV. However, Bynum et al.,
(2011) found that perceived severity was not a predictor of vaccine intake.
Perceived benefits. The research question sought to find out if there were any
relative contributions from perceived benefits to HPV vaccination intentions among male
and female Black college students. This study found that there was not a significant
interaction between perceived benefits and gender, in reference to their intent to receive
the HPV vaccination. However, female participants had 0.41 times less likelihood to plan
to receive the vaccination than males. In a study conducted by Darensbourg et al., (2019)
with African American college women, a study result was that vaccination intention had
a correlation with vaccination being seen as valuable. Unlike this study, a study
conducted at a HBCU in the southeastern United States found that participants in that
study would initiate the vaccine if the students perceived the benefit of being vaccinated
(Bynum et al., 2011).
Perceived barriers. The research question sought to find out if there were any
relative contributions from perceived barriers to HPV vaccination intentions among male
and female Black college students. This study found that there was not a significant
interaction between perceived barriers and gender, in reference to Black college students
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intent to receive the HPV vaccination. However, perceived barriers total scores
influenced plan to receive vaccination, participants were 0.80 times less likely to intend
to receive vaccination. Burke et al., (2010) found that barriers to vaccination were side
effects, costs, and lack of knowledge about the vaccine, as related to vaccine intentions.
LaJoie, Kerr, Clover, and Harper (2018) found that vaccine uptake was affected by the
individuals’ partners vaccination status; yet uptake was influenced by parental influence
and free vaccines.
Question 3
Trust/mistrust. The research question sought to find out if there were any
relative contributions from trust/mistrust to HPV vaccination intentions among male and
female Black college students. This study found that there was not a significant
interaction between trust/mistrust and gender, in reference to their intent to receive the
HPV vaccination (p=0.771). However, female participants had a 0.45 time less likelihood
to plan to receive the vaccination than males. Conversely, Karafillakis et al., (2019)
conducted a literature review and found that participants reported issues with concerns
about mistrust of health authorities in relationship to HPV vaccination and new vaccines.
Nan et al. (2019) found that low trust in health information from government entities was
linked to less favorable intentions toward vaccination. Similar to this study, Nan et al.
(2019) found that trust in health care providers did not predict vaccine uptake.
Social Influence. The research question sought to find out if there were any
relative contributions from social influence on HPV vaccination intentions among male
and female Black college students. This research found that there was not a significant
interaction between social influence and gender, in reference to their intent to receive the
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HPV vaccination. Conversely Daley et al. (2010) found that participants that received
HPV information from family and media sources were more likely to initiate the vaccine.
Similarly, Marchant, Glenn, and Bastani (2012) also found that the female participants
were likely to receive the vaccine if it had higher social approval.
Prior Sexual Behavior. The research question sought to find out if there were
any relative contributions from prior sexual behavior to HPV vaccination intentions
among male and female Black college students. This research found that there was not a
significant interaction between prior sexual behavior and gender, in reference to their
intent to receive the HPV vaccination. However, female participants had a 0.437 time less
likelihood to plan to receive the vaccination than males. Cooper et al., (2018) found that
Black men were less likely to identify as virgins, and more likely to be sexually active
and have an earlier sexual debut age compared to White, Asian, and other men. While,
Burke et al., (2010) found that 60.7% (n=856) of the participants in their study of
undergraduate college women, reported that they were not sexually active and that they
planned to be vaccinated. Researchers should take prior sexual behavior into
consideration when deciding interventions to prevent STIs, since HPV is spread via
sexual contact.
Question 4
Change in dosing. This research question sought to find out if a change from 3
doses to 2 doses would contribute on HPV vaccinations intentions in male and female
Black college students. Black college students did intend to become vaccinated since the
doses changed. This information is invaluable for health care providers and individuals
providing education regarding HPV vaccination. This research suggests that vaccination
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uptake will be positively influenced with the new dosing criteria. Quinn and Lewin
(2019) conducted a study at public university to determine family influence on vaccine
behavior. This study found that the more comprehensive family communication, the more
likely the participants were to have less uncertainty regarding HPV vaccine receipt and
greater likelihood of being previously vaccinated (Quinn and Lewin, 2019). LaJoie, Kerr,
Clover, and Harper (2018) found that parental influence and vaccinations being provided
at no charge were positive factors for vaccine uptake. While research has shown that the
intent to vaccinate is multifaceted, at this time, there was no research that looked at
vaccination dosage.
Limitations of Study
While this research was conducted quantitatively, qualitative research instruments
might helped explain some of the findings in this study. Carefully collected qualitative
information could help to explain some of the results that were found in these
participants. There were several limitations in this study. As previously mentioned, a
limitation was that some of the instruments used in this study had not been used in young
Black college student populations. The data obtained from this study may not be
applicable to all Black college students or Black people in general given its focus on four
colleges in the southeastern United States. General limitations for this study included
issues related to measurement and data collection, which relied on self-report
instruments. In spite of this limitations the study was designed to minimize data
collection limits.
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Participant Recruitment and Data Collection
Study participants were part of a convenience sample recruited from four college
locations. This method of recruitment can make study findings difficult to apply across
the total population. The access to the student populations at each site also became a
limitation in this study. The participants in 2 of the 4 sites were recruited from students in
a health science major, while the students in the other 2 sites were recruited from the
general population of students. The students recruited from the health science majors may
have been better informed regarding vaccination information in general.
Data Collection
Data collection by the instrument package was collected by the principal
investigator (PI). This was useful when the participants had questions regarding the
information being asked. However, some participants did not ask for clarity of questions
from the PI, they opted to ask another participant or the individual that told them about
the study. Since some of the questions asked for specific time frames for responses to
questions, some participants may not have had adequate recall of requested information,
thus data obtained were subject to recall error.
Design
Since this study was designed to be cross sectional, it would be difficult to assert
if the responses would be the same at different point in time. Therefore, if associations
were found between location and intent to vaccinate, there is no way to determine if
vaccine intentions would change based on the current place of study. This study did not
address the causes of the perceived vulnerability, severity, benefits, and barriers
(independent variables) and intent to vaccinate cannot be directly studied using binomial
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regression analysis. Also, the cause of trust/mistrust, social influence, and prior sexual
and intent to vaccinate cannot be determined given the correlational design of the study.
Variables
The inclusion and exclusion variables (descent, gender, immunization status,
college enrollment, age, literacy, and marital status) and college sites (HBCU, MSI, rural
or urban location), were selected to help control for confounding variables. Although this
was the intention of the researcher, changes in these variables could always occur and
influence individual’s intent to vaccinate. There could also be some other confounding
variables that may not have been identified.
Instruments
Some of the research instruments had language that did not have the same
meaning to participants. For example, in the SRS instrument, “hooking up,” “friends with
benefits,’’ ‘‘fuck buddies’’ could have varying meanings. As these colloquialisms can
change in time, they must be addressed within the participant populations.
Conclusions
Although the data from this study did not provide support for all the aims of this study,
the study data revealed the following results:
•

Gender influenced Black college students’ intention to vaccinate.

•

When it comes to perceived vulnerability (individuals’ risk of something
occurring to them), females did not plan to become vaccinated more than males.

•

When it comes to perceived severity (individuals’ thoughts on how serious
something is), perceived severity had an influence on intention to receive
vaccination.
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•

When it comes to perceived benefits (individuals thinking something has a
positive benefit), females did not plan to become vaccinated more than males.

•

When it comes to perceived barriers (what individuals believe), perceived barriers
have an influence on individuals’ intention to receive the vaccine, and higher
scores decreased the intentions to vaccinate.

•

When it came to trust/mistrust (individuals believing in something or not),
females were more likely not to plan to intend to receive vaccination.

•

When it comes to prior sexual behavior (an individual’s previous sexual activity),
females were more likely not to plan to intend to receive vaccination.

•

When it comes to the change in dosing from 3 doses to 2 doses, Black college
students were influenced by the dosing change.

•

Overall, males in this study were more likely than females to plan to intend to
become vaccinated.

•

Of the 157 participants in this study, 101 of them were “unsure” if they would
receive vaccination.

•

No significant statistical difference was found in age and location for Black
college students’ intention to vaccinate.

•

No statistical significance was found for the interaction between perceived
vulnerability, severity, benefits, or barriers and intention to vaccinate.

•

No statistical significance was found for the interaction between trust/mistrust,
social influence, or prior sexual behavior and intention to vaccinate.
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Based on these outcomes and findings and conclusions the following recommendations
are suggested for future clinical practice and research.
Recommendations for Future Research
•

The continued prevalence of the Black population being adversely affected by
STIs, and HPV reflects the importance of continued research in this population.

•

Additional data is needs to assess the factors that influence health decisions in this
vulnerable population, that is based on insight from the effected and the affected
population.

•

Males are underrepresented in the research on HPV vaccination and should be
included in research regarding this topic.

•

Some qualitative data might provide insight as to why the participants still are
“unsure” if they will receive vaccination.

•

There is an urgent need to develop and implement interventions to assist this
vulnerable population regarding sexual health.

•

Further investigation on the factors that influence vaccination uptake in this
population is warranted.

•

Studies should focus on increasing vaccination rates and educating vulnerable
populations.
Recommendations for Clinical Practice

•

Clinicians should continue to educate families regarding HPV vaccination.

•

Clinicians should screen for sexual risk factors and behavior when doing
anticipatory guidance for this population.
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•

Parents are not the only source of information for impressionable teenagers, and
this age group needs relevant information that they can easily understand.
Clinicians should step out of the office and be present where the students can
assess care and information readily.
Summary
This non-experimental, cross-sectional, descriptive study was executed to

determine if differences exist in individual perceptions, modifying factors, and likelihood
of action and the influence, if any, in vaccine naïve Black college students, attending
college in a rural or urban HBSUs and MSIs, intention to receive HPV vaccination. In
addition to this, this research explored rather the new policy on decreasing HPV dosage
from 3 shots to 2 shots in young adolescents will affect individuals’ intentions to
vaccinate. The Health Belief Model provided the theoretical basis for this study. Study
outcomes revealed that certain aims were confirmed, while others were not. As depicted
in the framework, gender and perceived severity and perceived barriers were predictive
of intentions to vaccinate; however, the other variables (age, location of college,
trust/mistrust, social influence, and prior sexual behavior) of this study were not found to
have relative contributions to intentions to receive the HPV vaccination. Also, it was
found that the change is dosing has a relative contribution to Black college students
receiving the HPV vaccine. During this study numerous limitations and strengths were
noted. While this study only found slight support for the theoretical framework, pertinent
suggestions for future clinical practice and research were found.

110

Reference
Abiola, S. E., Colgrove, J., & Mello, M. M. (2013). The politics of HPV vaccination
policy in the United States. Journal of Health Politics, Policy, and Law, 38(4).
doi: 10.1215/03616878-2208567
Adams, M., Jasani, B., & Fiander, A. (2007). Human papilloma virus (HPV)
prophylactic vaccination: Challenges for public health and implications for
screening. Vaccine, 25(16), 3007-3013.
Allen, J. D., Mohllajee, A.P., Shelton, R.C., Othus, M.K., Fontenot, H.B., & Hanna, R.
(2009). Stage of adoption of the human papillomavirus vaccine among college
women. Preventative Medicine, 48(5), 420-425. doi:
10.1016/j.ypmed.2008.12.005
American Cancer Society (ACS). (2013). Cancer facts and figures for African
Americans 2013-2014. Retrieved from
http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/
document/acspc-036921.pdf
American Cancer Society (ACS). (2016). Cancer facts & figures for African Americans
2016-2018. Retrieved from https://www.cancer.org/content/dam/cancerorg/research/cancer-facts-and-statistics/cancer-facts-and-figures-for-africanamericans/cancer-facts-and-figures-for-african-americans-2016-2018.pdf
American College of Obstetricians and Gynecologist (ACOG). (2017). Cervical cancer
screening. Retrieved from https://www.acog.org/Patients/FAQs/Cervical-CancerScreening
American College Health Association. (2018). American College Health AssociationNational College Health Assessment II: Reference Group Undergraduates
Executive Summary Fall 2017. Hanover, MD: American College Health
Association. Retrieved from: https://www.acha.org/documents/ncha/NCHAII_FALL_2017_REFERENCE_GROUP_EXECUTIVE_SUMMARY_UNDERG
RADS_ONLY.pdf
Armstrong, E.P. (2010). Prophylaxis of cervical cancer and related cervical disease: A
review of the cost-effectiveness of vaccination against oncogenic HPV types.
Journal of Managed Care Pharmacy, 16(3), 217-230.
Association of Reproductive Health Professionals. (2013). Managing HPV: A new era in
patient care. Retrieved from http://www.arhp.org/publications-andresources/quick-reference-guide-for-clinicians/managing-hpv/Screening

111

Bandura, A., & Walters, R. H. (1977). Social learning theory (Vol. 1). Englewood Cliffs,
NJ: Prentice-Hall.
Barnard, M., George, P., Perryman, M. L., & Wolff, L. A. (2017). Human papillomavirus
(HPV) vaccine knowledge, attitudes, and uptake in college students: Implications
from the Precaution Adoption Process Model. PloS one, 12(8), e0182266. doi:
10.1371/journal.pone.0182266
Barnett, K. S., Shoben, A. B., McRee, A. L., Reiter, P. L., Paskett, E. D., & Katz, M. L.
(2016). Human papillomavirus vaccine and Pap tests on college campuses: How
do historically black colleges and universities (HBCUs) measure up? Journal of
American College Health, 64(8), 613-618. doi: 10.1080/07448481.2016.1213731
Bednarczyk, R. A., Davis, R., Ault, K., Orenstein, W., & Omer, S. B. (2012). Sexual
activity–related outcomes after human papillomavirus vaccination of 11-to 12year-olds. Pediatrics, 130(5), 798-805. doi: 10.1542/peds.2012-1516.
Bendik, M. K., Mayo, R. M., & Parker, V. G. (2011). Knowledge, perceptions, and
motivations related to HPV vaccination among college women. Journal of Cancer
Education, 26(3): 459-464 doi: 10.1007/s13187-011-0200-8
Bosch, F. X., & De Sanjosé, S. (2003). Chapter 1: Human papillomavirus and cervical
cancer—burden and assessment of causality. JNCI Monographs, 2003(31), 3-13.
Boulware, L. E., Cooper, L. A., Ratner, L. E., LaVeist, T. A., & Powe, N. R. (2003).
Race and trust in the health care system. Public Health Reports, 118(4), 358–365.
doi: 10.1016/S0033-3549(04)50262-5
Brandon, D. T., Isaac, L. A. & LaVeist, T. A. (2005). The legacy of Tuskegee and trust in
medical care: Is Tuskegee responsible for race differences in mistrust of medical
care? Journal of the National Medical Association, 97(7), 951-956.
Brisson, M., Van de Velde, N., & Boily, M. C. (2009). Economic evaluation of human
papillomavirus vaccination in developed countries. Public Health Genomics,
12(5-6), 343-351. doi: 10.1159/000214924
Bruni, L., Barrionuevo-Rosas, L., Albero, G., Serrano, B., Mena, M., Gómez, D., ... & De
Sanjosé, S. (2017). ICO/IARC information centre on HPV and cancer (HPV
information centre). Human papillomavirus and related diseases in the world.
Summary report, 27.
Bruni, L., Barrionuevo-Rosas, L., Serrano, B. et al. (2014) ICO information centre on
HPV and Cancer (HPV information centre). Human papillomavirus and related
diseases in world. Summary report 2014-08- 22.
(http://www.hpvcentre.net/statistics/reports/XWX.pdf); Accessed on 2014-08-22

112

Bruni, L., Barrionuevo-Rosas, L., Albero, G., Aldea, M., Serrano, B., Valencia, S.,
Brotons, M., Mena, M., Cosano, R., Munoz, J., Bosch, F. X., de Sanjose, S., &
Castellsague, X. (2015). Human papillomavirus and related diseases in the world.
Information Centre on HPV and Cancer (HPV information Centre). Summary
Report 2015-04-08. Retrieved from
www.hpvcentre.net/statistics/reports/XWX.pdf
Burak, L. J., & Meyer, M. (1997). Using the Health Belief Model to examine and predict
college women's cervical cancer screening beliefs and behavior. Health Care of
Women International, 18(3), 251-262.
Burke, S. C., Vail-Smith, K., White, D. M., Baker, E., & Mitchell, T. (2010). Getting
vaccinated against HPV: Attitudes, intentions and perceived barriers of female
undergraduates. College Student Journal, 44(1), 55-64.
Bynum, S. A., Brandt, H. M., Annang, L., Friedman, D. B., Tanner, A., & Sharpe, P. A.
(2011). Do health beliefs, health care system distrust, and racial pride influence
HPV vaccine acceptability among African American college females? Journal of
Health Psychology, 17(2), 217-226. doi: 10.1177/1359105311412833
Caron, R.M., Kispert, E., & McGrath, M. J. (2008). College women’s attitudes,
behaviors, and beliefs regarding the HPV vaccine: Translation to health education
and practice. Retrieved from http://eric.ed.gov/?id=ED502309
Carpenter, W. R., Godley, P. A., Clark, J. A., Talcott, J. A., Finnegan, T., Mishel, M.,
Bensen, J., Rayford, W., Su, J., Fontham, E. T. H., & Mohler, J. L. (2009). Racial
differences in trust and regular source of patient care and the implications for
prostate cancer screening use. Cancer, 115(21), 5048-5059. doi
10.1002/cncr.24539
Caskey, R., Lindau, S. T., & Alexander, G. C. (2009). Knowledge and early adoption of
the HPV vaccine among girls and young women: Results of a national
survey. Journal of Adolescent Health, 45(5), 453-462.
Cavazos-Rehg, P.A., Krauss, M.J., Spitznagel, E., Schootman, M., Bucholz, K.K.,
Peipert, J.F., Sanders-Thompson, V., Cottler, L.B., Bierut, L.J. (2009). Age of
sexual debut among U.S. adolescents. Contraception, 80(2), 158-162.
Centers for Disease and Prevention (CDC). (1996). Youth risk behavior surveillance:
National college health risk behavior survey-United States, 1995. Morbidity and
Mortality Weekly Report, 45(SS-4). Retrieved from
http://www.google.com/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1
&ved=0CCMQFjAA&url=http%3A%2F%2Fwww.cdc.gov%2Fmmwr%2FPDF%

113

2FSS%2FSS4504.pdf&ei=eTRBVbi6Mo_hsASKj4D4Cw&usg=AFQjCNExHyA
Qspi4QS_SyYHaZ2olY6Gu-w&bvm=bv.92189499,d.b2w
Centers for Disease and Prevention (CDC). (1999). Prevention of genital HPV infection
and sequelae: Report of an external consultant’s meeting. Retrieved from
http://www.cdc.gov/nchstp/dstd/Reports_Publications/99HPVReport.htm

Centers for Disease and Prevention (CDC). (2007). Quadrivalent human papillomavirus
vaccine: Recommendations of the advisory committee on immunizations
practices. Morbidity and Mortality Weekly Report, 56(RR02), 1-24. Retrieved
from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm
Centers for Disease and Prevention (CDC). (2010). National, State, and local area
vaccination coverage among adolescent aged 13-17 years-United States, 2009.
Morbidity and Mortality Weekly Report, 59, 1018-1023.
Centers for Disease and Prevention (CDC). (2011). The national health interview survey
(NHIS) 2009 adult vaccination coverage. Retrieved from
http://www.cdc.gov/vaccines/imz-managers/coverage/nhis/2009-nhis.html
Centers for Disease and Prevention (CDC). (2012a). Sexually transmitted diseases
(STDs). Retrieved from http://www.cdc.gov/std/hpv/stdfact-hpv.htm
Centers for Disease and Prevention (CDC). (2012b). Human papillomavirus (HPV)associated cancers. Retrieved from http://www.cdc.gov/cancer/hpv/statistics/
Centers for Disease and Prevention (CDC). (2013). Human Papillomavirus (HPV)associated cancers. Retrieved from http://www.cdc.gov/cancer/hpv/statistics/
Centers of Disease Control and Prevention (CDC). (2015a). Genital HPV infection-fact
sheet. Retrieved from http://www.cdc.gov/std/HPV/STDFact-HPV.htm#a7
Center for Disease Control and Prevention (CDC). (2015b). STDs in racial and
ethnic minorities. Retrieved from http://www.cdc.gov/std/stats14/minorities.htm
Center for Disease Control and Prevention (CDC). (2015c). Teen vaccination coverage.
Retrieved from http://www.cdc.gov/vaccines/parents/vacc-coverage-teens.html
Centers of Disease Control and Prevention (CDC). (2015d). Use of 9-valent human
papillomavirus (HPV) vaccine: Updated HPV vaccination recommendations of
the advisory committee on immunization practices. Morbidity and Mortality
Weekly Report, 64(11), 300-304. Retrieved from
http://www.cdc.gov/mmWr/preview/mmwrhtml/mm6411a3.htm

114

Center for Disease Control and Prevention (CDC). (2016a). CDC recommends only
two HPV shots for younger adolescents. Retrieved from
https://www.cdc.gov/media/releases/2016/p1020-hpv-shots.html
Centers for Disease and Prevention (CDC). (2016b). HPV vaccine coverage mapsinfographic. Retrieved from https://www.cdc.gov/hpv/infographics/vacccoverage.html
Center for Disease and Prevention (CDC). (2016c). Less HPV infections mean healthier
communities of color. Retrieved from http://www.cdc.gov/features/preventhpv/
Centers of Disease Control and Prevention (CDC). (2016d). The link between HPV and
cancer. Retrieved from https://www.cdc.gov/hpv/parents/cancer.html
Centers for Disease and Prevention (CDC). (2017a). Adolescents and young adults.
Retrieved from https://www.cdc.gov/std/life-stages-populations/adolescentsyoungadults.htm
Centers of Disease Control and Prevention (CDC). (2017b). Genital HPV infection- fact
sheet. Retrieved from: https://www.cdc.gov/std/hpv/stdfact-hpv.htm
Centers of Disease Control and Prevention (CDC). (2017c). HPV vaccine information
for young women. Retrieved from: https://www.cdc.gov/std/hpv/stdfact-hpvvaccine-young-women.htm
Centers for Disease and Prevention (CDC). (2018a). HPV-associated cancers rates by
race and ethnicity. Retrieved from
https://www.cdc.gov/cancer/hpv/statistics/race.htm
Centers of Disease Control and Prevention (CDC). (2018b). HPV vaccination coverage
data. Retrieved from: https://www.cdc.gov/hpv/hcp/vacc-coverage/index.html
Centers of Disease Control and Prevention (CDC). (2018c). Infographic: Screening won’t
protect your patients from most HPV cancers.) Retrieved from
https://www.cdc.gov/hpv/hcp/hpv-important/more-than-screeninginfographic.html
Centers for Disease and Prevention (CDC). (2018d). National, Regional, State,
and Selected Local Area Vaccination Coverage among Adolescents Aged 13–17
Years — United States, 2017. Morbidity and Mortality Weekly Report , 67(33).
Retrieved from https://stacks.cdc.gov/view/cdc/58073
Centers of Disease Control and Prevention (CDC). (2018e). Other STDS. Retrieved from
https://www.cdc.gov/std/stats17/other.htm#ref25

115

Centers of Disease Control and Prevention (CDC). (2018f). Why is HPV vaccine
important? Retrieved from https://www.cdc.gov/hpv/hcp/hpv-important.html
Centers of Disease Control and Prevention (CDC). (2019a). How many cancers are
linked with HPV each year? Retrieved from
https://www.cdc.gov/cancer/hpv/statistics/cases.htm
Centers of Disease Control and Prevention (CDC). (2019b). HPV-associated cancers
rates by race and ethnicity. Retrieved from
https://www.cdc.gov/cancer/hpv/statistics/race.htm
Centers of Disease Control and Prevention (CDC). (2019c). HPV diseases and cancers.
Retrieved from https://www.cdc.gov/hpv/parents/cancer.html
Centers of Disease Control and Prevention (CDC). (2019d). Reasons to get vaccinated.
Retrieved from https://www.cdc.gov/hpv/parents/vaccine/six-reasons.html
Clark, C. C., & Paraska, K. (2014). Health promotion for nurses: A practical guide. Jones
& Bartlett Publishers.
Clark, C., & Paraska, K. (2012). Health promotion for nurses: A practical guide. Jones &
Bartlett Publishers.
Chesson, H.W., Ekwueme, D. U., Saraiya, M., Dunne, E. F., Markowitz, L. E. (2011).
The cost effectiveness of male HPV vaccination in the United States. Vaccine, 29,
8443-8450. doi: 10.1016/j.vaccine.2011.07.096
Chesson, H. W., Ekwueme, D. U., Saraiya, M., Watson, M., Lowy, D. R., & Markowitz,
L. E. (2012). Estimates of the annual direct medical costs of the prevention and
treatment of disease associated with human papillomavirus in the United States.
Vaccine, 30(42), 6016-6019. doi: 10.1016/j.vaccine.2012.07.056
Constantine, N. A., & Jerman, P. (2007). Acceptance of human papillomavirus
vaccination among Californian parents of daughters: A representative statewide
analysis. Journal of Adolescent Health, 40(2), 108-115. doi:
10.1016/j.jadohealth.2006.10.007
Cook, R. L., Zhang, J., Mullins, J., Kauf, T., Brumback, b., Steingraber, H., & Mallison,
C. (2010). Factors associated with initiation and completion of human
papillomavirus vaccine series among young women enrolled in Medicaid. Journal
of Adolescent Health, 47(6), 596-599. doi: 10.1016/j.jadohealth.2010.09.015.

116

Cooper, D. L., Zellner-Lawrence, T., Mubasher, M., Banerjee, A., & Hernandez, N. D.
(2018). Examining HPV awareness, sexual behavior, and intent to receive the
HPV vaccine among racial/ethnic male college students 18–27 years. American
Journal of Men's Health, 12(6), 1966-1975.
Cuffee, Y. L., Hargraves, J. L., Rosal, M., Briesacher, B. A., Schoenthaler, A., Person, S.,
... & Allison, J. (2013). Reported racial discrimination, trust in physicians, and
medication adherence among inner-city African Americans with hypertension.
American Journal of Public Health, 103(11), e55-e62.
Cutts, F. T., Franceschi, S., Goldie, S., Castellsaque, X., De Sanjose, S., Garnett, G.,
Edmunds, W. J., Claeys, P., Goldenthal, K. L., Harper, D. M. & Markowitz, L.
(2007). Human papillomavirus and HPV vaccines: A review. Bulletin of the
World Health Organization, 85(9), 719-726.
Daley, E. M., Vamos, C. A., Buhi, E. R., Kolar, S. K., McDermott, R. J., Hernandez, N.,
& Fuhrmann, H. J. (2010). Influences on human papillomavirus vaccination status
among female college students. Journal of Women’s Health, 19 (10), 1885-1891.
doi: 10.1089/jwh.2009.1861
Daley, E.M., Marhefka, S., Buhi, E., Hernandez, N.D., Chandler, R., Vamos, C., &
Guiliano, A., R. (2011). Ethnic and racial differences in HPV knowledge and
vaccine intentions among men receiving HPV test results. Vaccine, 29(23), 40134018. doi: 10.1016/j.vaccine.2011.03.060
Darensbourg, L. R., López, I. A., Dutton, M. T., & Brown, C. P. (2015). Knowledge and
Perceptions of HPV Vaccine Acceptance among African-American College
Women. Florida Public Health Review, 12(1), 5.
Fontenot, H. B., Collins Fantasia, H., Charyk, A., & Sutherland, M. A. (2014). Human
papillomavirus (HPV) risk factors, vaccination patterns, and vaccine perceptions
among a sample of male college students. Journal of American College
Health, 62(3), 186-192.
Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2011). Worsening disparities in HPV
vaccine utilization among 19–26-year-old women. Vaccine, 29(3), 528-534.
Dempsey A. F., & Davis, M. M. (2006). Overcoming barriers to adherence to HPV
vaccination recommendations. American Journal of Managed Care, 12, 484-491.
Dorell, C., Yankey, D., & Strasser, S. (2011). Parent-reported reasons for nonreceipt of
recommended adolescent vaccinations, national immunization survey—teen,
2009. Clinical Pediatrics, 50(12), 1116–1124. doi: 10.1177/0009922811415104

117

Dunne, E. F., Sternberg, M., Markowitz, L. E., McQuillan, G., Swan, D., Patel, S., &
Unger, E. R. (2011). Human Papillomavirus (HPV) 6, 11, 16, and 18 prevalence
among females in the United States—national health and nutrition examination
survey, 2003–2006: Opportunity to measure HPV vaccine impact. The Journal of
Infectious Diseases, 204(4), 562-565. doi: 10.1093/infdis/jir342
D’Urso, J., Thompson-Robinson, M. & Chandler, S. (2007). HPV knowledge and
behaviors of black college students at a historically black university. Journal of
American College Health, 56(2), 159-163.
Erdman, J. M. (2008). Health Equity: HPV and the Cervical Cancer Vaccine. Special Ed.
Health LJ, 127.
Fazekas, K. I., Brewer, N. T., & Smith, J. S. (2008). HPV vaccine acceptability in a rural
southern area. Journal of Women’s Health, 17(4), 539-548. doi:
10.1089/jwh.2007.0489
Fenkl, E., Hughes, I., & Jones, S. G. (2016). Human papillomavirus knowledge and
intent to vaccinate among young college age males. Journal of Epidemiological
Research, 2(2), 108. doi: https://doi.org/10.5430/jer.v2n2p108
Ford, J. L. (2011). Racial and ethnic disparities in human papillomavirus awareness and
vaccination among young adult women. Public Health Nursing 28(6), 485-493
doi: 10.111/j.1525-1446.2011.00958.x
Freed, G. L., Clark, S. J., Butchart, A. T., Singer, D. C., & Davis, M. M. (2011). Sources
and perceived credibility of vaccine-safety information for parents. Pediatrics,
peds-2010. doi:10.1542/peds.2010-1722P
Giuliano, A. R., Beibei, L, Nielson, C. M., Flores, R., Papenfuss, M. R., Lee, J.,
Abrahamsen, M., & Harris, R. B., (2008). Age-specific prevalence, incidence, and
duration of human papillomavirus infections in a cohort of 290 US men. The
Journal of Infectious Disease, 198(6), 827-835. doi: 10.1086/591095.
Glanz, K., Rimer, B. K., & Lewis, F. M. (2002). Health behavior and health education.
theory, research and practice. (52). San Francisco: Wiley & Sons. Retrieved from
https://www.utwente.nl/cw/theorieenoverzicht/Theory%20Clusters/Health%20Co
mmunication/Health_Belief_Model/
Habel, M. A., Coor, A., Beltran, O., Becasen, J., Pearson, W. S., & Dittus, P. (2018). The
state of sexual health services at US colleges and universities. Journal of
American College Health, 66(4), 259-268. doi: 10.1080/07448481.2018.1431896

118

Hawe, P., McKenzie, N., & Scurry, R. (1998). Randomized controlled trial of the use of a
modified postal reminder card on the uptake of measles vaccination. Archives of
Disease in Childhood, 79(2), 136-140
Hippeläinen, M., Syrjänen S., Hippeläinen M., Koskela H., Pulkkinen J., Saarikoski S, &
Syrjänen K. (1993). Prevalence and risk factors of genital human papillomavirus
(HPV) infections in healthy males: A study on Finnish conscripts. Sexually
Transmitted Disease, 20(6), 321-328.
Hirth, J. M., Batuuka, D. N., Gross, T. T., Cofie, L., & Berenson, A. B. (2018). Human
papillomavirus vaccine motivators and barriers among community college
students: Considerations for development of a successful vaccination program.
Vaccine, 36(8), 1032-1037. doi: 10.1016/j.vaccine.2018.01.037.
Holt, C. L., Clark, E. M., Roth, D. L., Crowther, M., Kohler, C., Fouad, M., Foushee, R.,
Lee, P. A., & Southward, P. L. (2010). Development and validation of an
instrument to assess perceived social influence on health behaviors. Journal of
Health Psychology, 15(8), 1225-1235. doi: 10.1177/1359105310365178
Hopkins, T. G., & Wood, N. (2013). Female human papillomavirus (HPV) vaccination:
Global uptake and the impact of attitudes. Vaccine, 31(13), 1673-1679. doi:
10.1016/j.vaccine.2013.01.028
Hoy, T., Singhal, P. K., Wiley, V. J., & Insinga, R. P. (2009). Assessing incidence and
economic burden of genital warts with data from a US commercially insured
population. Current Medical Research and Opinion, 25(10), 2343-2351. doi:
10.1185/03007990903136378
Hsu, Y. Y., Fetzer, S. J., Chang, Y. Y. Huang, C. P., & Chou, C. Y. (2009). Intention to
btain human papillomavirus vaccination among Taiwanese undergraduate women.
Sexually Transmitted Diseases, 36(11), 686–69.
Hu, D. & Goldie, S. (2008). The economic burden of noncervical human papillomavirus
disease in the United States. American Journal of Obstetrics and Gynecology,
198(5), 500 e1-e7. doi: 10.1016/j.ajog.2008.03.064.
Jain, N., Euler, G. L., Shefer, A., Lu, P., Yankey, D., & Markowitz, L., (2009). Human
papillomavirus (HPV) awareness and vaccination initiation among women in the
United States, national immunization survey-adult 2007. Preventive Medicine,
48(5), 426-431.
Jones, M. & Cook, R. (2008). Intent to receive an HPV vaccine among university men
and women and implications for vaccine administration. Journal of American
College Health, 57(1), 23-31.

119

Jones, S. G., Mathis-Gamble, K., & Fenkl, E. A. (2017). Minority College Students' HPV
Knowledge, Awareness, and Vaccination History. Journal of the Association of
Nurses in AIDS Care, 28(5), 675-679. doi: 10.1016/j.jana.2017.04.008
Karafillakis, E., Simas, C., Jarrett, C., Verger, P., Peretti-Watel, P., Dib, F., ... & Larson,
H. (2019). HPV vaccination in a context of public mistrust and uncertainty: A
systematic literature review of determinants of HPV vaccine hesitancy in
Europe. Human Vaccines & Immunotherapeutics, 15(7-8), 1615-1627.
Kester, L. M., Zimet, G. D., Fortenberry, J. D., Kahn, J. A., & Shew, M. L. (2013). A
national study of HPV vaccination of adolescent girls: Rates, predictors, and
reasons for non-vaccination. Maternal and Child Health Journal, 17(5), 879-885.
Kim, J. J. (2011). Weighing the benefits and costs of HPV vaccination of young men. The
New England Journal of Medicine, 364(5), 393-395.
Koplas, P. A., Braswell, J., & Saray-Smalls, T. (2019). Uptake of HPV vaccine in
traditional-age undergraduate students: Knowledge, behaviors, and
barriers. Journal of American College Health, 67(8), 762-771.
Laerd Statistics (2017). Binomial logistic regression using SPSS Statistics. Statistical
tutorials and software guides. Retrieved from https://statistics.laerd.com/
Laerd Statistics (2017). Statistical tutorials and software guides. Retrieved from
https://statistics.laerd.com/
LaJoie, A. S., Kerr, J. C., Clover, R. D., & Harper, D. M. (2018). Influencers and
preference predictors of HPV vaccine uptake among US male and female young
adult college students. Papillomavirus Research, 5, 114-121. doi:
https://doi.org/10.1016/j.pvr.2018.03.007
LaVeist, T. A., Isaac, L. A., & Williams, K. P. (2009). Mistrust of health care
organizations is associated with underutilization of health services. Health
Services Research, 44(6), 2093-2105. doi: 10.1111/j.1475-6773.2009.01017.x.
Larson, E. B., Bergman, J., Heidrich, F., Alvin, B. L., & Schneeweiss, R. (1982). Do
postcards improve influenza vaccination compliance? Medical Care, 20(6), 639648.
Lee, H. Y., Lust, K., Vang, S., & Desai, J. (2018). Male undergraduates’ HPV
vaccination behavior: Implications for achieving HPV-associated cancer equity.
Journal of Community Health, 1-8. doi: 10.1007/s10900-018-0482-4.

120

Leichliter, J.S., Copen, C., & Dittus, P.J. (2017). Confidentiality issues and use of
sexually transmitted disease Services Among Sexually Experienced Persons Aged 15–25
Years — United States, 2013–2015. Morbidity and Mortality Weekly Report 2017, 66,
237–241. doi: http://dx.doi.org/10.15585/mmwr.mm6609a1.
Levin, K. A. (2006). Study design III: Cross sectional studies. Evidence-Based Dentistry,
7(1), 24-25. doi: 10.1038/sj.ebd.640037510.1038/sj.ebd.6400375
Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012). Human papillomavirus
vaccine and sexual behavior among adolescent and young women. American
Journal of Preventive Medicine, 42(1), 44-52. doi: 10.1016/j.amepre.2011.09.024.
Linnehan, M. J. E., & Groce, N. E. (1999). Psychosocial and educational services for
female college students with genital human papillomavirus infection. Family
planning perspectives, 137-141.
Los Angeles Community College District. (2011). Research and statistics: Student
characteristics. http://research.laccd.edu/student-characteristics/index.htm.
Manhart, L. E., Burgess-Hall, A. J., Fleming, C. B., Bailey, J. A., Haggerty, K. P., &
Catalano, R. F. (2011). HPV vaccination among a community sample of young
adult women. Vaccine, 29(32), 5238-5244. doi:10.1016/j.vaccine.2011.05.024
Marchand, E., Glenn, B. A., & Bastani, R. (2012). Low HPV vaccine coverage among
female community college students. Journal of community health, 37(6), 11361144. Doi: https://doi.org/10.1007/s10900-012-9572-x
Matthews KA, Croft JB, Liu Y, et al. Health-Related Behaviors by Urban-Rural County
Classification — United States, 2013. Morbidity and Mortality Weekly Report
Summ 2017, 66(No. SS-5), 1–8. doi: http://dx.doi.org/10.15585/mmwr.ss6605a1.
Matthews, K. A., Croft, J. B., Liu, Y., Lu, H., Kanny, D., Wheaton, A. G., ... & Eke, P. I.
(2017). Health-related behaviors by urban-rural county classification—United
States, 2013. MMWR Surveillance Summaries, 66(5), 1. DOI:
http://dx.doi.org/10.15585/mmwr.ss6605a1.
Max, W., Rice, D.P., Sung, HY., Michel, M., Breuer, W., Zhang, X. (2003). The
economic burden of gynecologic cancers in California, 1998. Gynecologic
Oncology, 88(2), 96-103.
McCrum-Gardner, E. (2010). Sample size and power calculations made simple.
International Journal of Therapy and Rehabilitation, 17(1), 10-14. doi:
http://dx.doi.org/10.12968/ijtr.2010.17.1.45988

121

Meites E, Kempe A, Markowitz LE. (2017). Use of a 2-Dose Schedule for Human
Papillomavirus Vaccination — Updated Recommendations of the Advisory
Committee on Immunization Practices. Morbidity and Mortality Weekly Report
Rep 2016;65:1405–1408. doi: http://dx.doi.org/10.15585/mmwr.mm6549a5.
Retrieved from: https://www.cdc.gov/mmwr/volumes/65/wr/mm6549a5.htm
Munoz, N., Bosch, X., de Saniose, S., Herrero, R., Castellsague, X., Shah, K. V.,
Snijders, P. J. F., & Meijer, C. J. L. M. (2003). Epidemiologic classification of
human papillomavirus types associated with cervical cancer. The New England
Journal of Medicine, 348(6), 518-527. doi: 10.1056/NEJMoa021641
Nan, X., Daily, K., Richards, A., Holt, C., Wang, M. Q., Tracy, K., & Qin, Y. (2019).
The role of trust in health information from medical authorities in accepting the
HPV vaccine among African American parents. Human Vaccines &
Iimmunotherapeutics, 15(7-8), 1723-1731.
Nan, X., Zhao, X., & Briones, R. (2014). Parental cancer beliefs and trust in health
information from medical authorities as predictors of HPV vaccine
acceptability. Journal of Health Communication, 19(1), 100-114.
10.1080/10810730.2013.811319.
National Conference of State Legislatures. (2009). School Immunization Exemption State
Laws. Retrieved from www. ncls.org/Default.aspx?TabId=14376
Niccolai, L. M., Mehta, N. R., & Hadler, J. L. (2011). Racial/ethnic and poverty
disparities in human papillomavirus vaccination completion. American Journal of
Preventative Medicine, 41(4), 428-433. doi: 10.1016/j.amepre.2011.06.032.
Oswalt, S. B., & Wyatt, T. J. (2013). Sexual health behaviors and sexual orientation in a
US national sample of college students. Archives of Sexual Behavior, 42(8), 15611572. doi: 10.1007/s10508-012-0066-9
Outterson, K. (2009). Foreword--Will HPV vaccines prevent cervical cancers among
poor women of color?: Global health policy at the intersection of human rights
and intellectual property law. American Journal of Obstetrics and Gynecology,
35(2-3), 247-252.
Painter, J.E., Borba, C.P., Hynes, M., Mays, D., & Glanz, K. (2008). The use of theory in
health behavior research from 2000 to 2005: A systematic review. Annals of
Behavioral Medicine, 35(3), 358–362.
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005). Global cancer statistics, 2002. A
Journal for Cancer Clinicians, 55(2), 74-108.

122

Patel, D. A., Zochowski, M., Peterman, S., Dempsey, S. F., Ernst, S. & Dalton, V. K.
(2012). Human papillomavirus vaccine intent and uptake among female college
students. Journal of American College Health, 60(2), 151-161.
Patridge, J.M., Hughes, J. P., Feng, Q., Winer, R. L., Weaver, B. A., Xi, L. F., Stern, M.
E., Lee, S. K., O’Reilly, S. F., Hawes, S. E., Kiviat, N. B., & Koutsky, L. A.
(2007). Genital human papillomavirus infection in men: incidence and risk factors
in a cohort of university students. Journal of Infectious Disease, 196(8), 11281136.
Polit, D. F. & Beck, C. T. (2004). Nursing research principles and methods (7th ed.).
Philadelphia, PA: Lippincott Williams & Wilkins.
Quinn, D. A., & Lewin, A. (2019). Family factors associated with emerging adults’
human papillomavirus vaccine behavior. Journal of American College Health, 18.
Rambout, L., Tashkandi, M., Hopkins, L., & Tricco, A. C. (2014). Self-reported barriers
and facilitators to preventive human papillomavirus vaccination among adolescent
girls and young women: A systematic review. Preventive Medicine, 58(1), 22-32.
doi: 10.1016/j.ypmed.2013.10.009
Ratanasiripong, N. T. (2012). A review of human papillomavirus (HPV) infection and
HPV vaccine-related attitudes and sexual behaviors among college-aged women
in the United States. Journal of American College Health, 60(6), 461-470.
Rose, A., Peters, N., Shea, J. A., & Armstrong, K. (2004). Development and testing of the
health care system distrust scale. Journal of General Internal Medicine, 19(1), 5763.
Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education
Monographs, 2(4), 328–335.
Rosenstock, I., Stretcher, V., & Becker, M. (1988). Social learning theory and the health
belief model. Health education quarterly, 15(2), 175-183.
Saraiya, M., Ahmen, F., Krishnan, S., Richards, T. B., Unger, E.R., & Lawson, H. W.
(2007). Cervical cancer incidence in a prevaccine era in the United States, 19982002. Obstetrics and Gynecology, 109(2 Pt 1), 360-370.
Scarinci, I. C., Garces-Palacio, I.C., & Patridge, E. E. (2007). An examination of
acceptability of HPV vaccination among African American women and Latina
immigrants. Journal of Women’s Health, 16(8), 1224-1233.

123

Schulterman, N. H., Terplan, M., Lydecker, A. D., & Tracy, J. K. (2011). Human
papillomavirus (HPV) vaccine uptake and completion at an urban hospital.
Vaccine, 12(29), 3767-3772. doi: 10.1016/j.vaccine.2011.03.032.
Singh, G. K., Miller, B. A., Hankey, B. F., & Edwards, B. K. (2004). Persistent area
socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage,
and survival, 1975-2000. Cancer, 101(5), 1051-1057.
Snyder, T.D., Dillow, S.A., and Hoffman, C.M. (2009). Digest of Education Statistics
2008 (NCES 2009-020). National Center for Education Statistics, Institute of
Education Sciences, U.S. Department of Education. Washington, DC.
Staples, J. N., Wong, M. S., & Rimel, B. J. (2018). An educational intervention to
improve human papilloma virus (HPV) and cervical cancer knowledge among
African American college students. Gynecologic oncology, 149(1), 101-105. doi:
10.1016/j.ygyno.2017.10.015.
Stephens, D. P., Tamir, H., & Thomas, T. L. (2016). Factors motivating HPV vaccine
uptake among vaccinated and nonvaccinated Hispanic young adult women.
Hispanic Health Care International, 14(4), 184-191.
Stephens, D. P., & Thomas, T. L. (2014). Social networks influence Hispanic college
women's HPV vaccine uptake decision-making processes. Women's Reproductive
Health, 1(2), 120-137.
Stretcher, V. & Rosenstock, I. (1997). The health belief model. In K. Glanz, I. Lewis, &
B. Rimer (Eds), Health behavior and health education: Theory, research, and
practice (pp. 31035). San Francisco, CA: Jossey-Bass.
Thomas, T. L. (2008). The new human papillomavirus (HPV) vaccine: Pros and cons for
pediatric and adolescent health. Pediatric Nursing, 34(5), 429-431.
Thomas, T. L. (2016). Cancer prevention: HPV vaccination. Seminars in Oncology
Nursing, 32(3), 273–280. http://doi.org/10.1016/j.soncn.2016.05.007
Thomas, T., Blumling, A., & Delaney, A. (2015). The influence of religiosity and
spirituality on rural parents’ health decision-making and human papillomavirus
vaccine choices. Advances in Nursing Science, 38(4), E1. doi:
10.1097/ANS.0000000000000094
Thomas, T. L., Dalmida, S., & Higgins, M. (2016). The student human papillomavirus
survey: Nurse led instrument development and psychometric testing to increase
HPV vaccine series completion in young adults. The Journal of Nursing
Measurement, 24(2), 226-244. doi: 10.1891/1061-3749.24.2.226.

124

Thomas, T. L., DiClemente, R., & Snell, S. (2014). Overcoming the triad of rural health
disparities: How local culture, lack of economic opportunity, and geographic
location instigate health disparities. Health Education Journal, 73(3), 285-294.
Thomas, T. L., & Freeman, A. (2011). Project genesis: Self-reported religiosity and
spirituality and sexual risk-taking in young African-American women attending a
historically African-American college. Journal of National Black Nurses
Association, 22(1), 27.
Thomas, T. L., Stephens, D. P., Johnson-Mallard, V., & Higgins, M. (2016). Young
Hispanic men and human papillomavirus vaccination choices. Journal of
Transcultural Nursing, 27(2), 103-108. doi: 10.1177/1043659614526759
Thomas, T. L., Strickland, O., Diclemente, R., & Higgins, M. (2013). An opportunity for
cancer prevention during preadolescence and adolescence: Stopping human
papillomavirus (HPV)-related cancer through HPV vaccination. Journal of
Adolescent Health, 52(5), S60-S68. doi: 10.1016/j.jadohealth.2012.08.011
Thomas, T. L., Strickland, O. L., DiClemente, R., Higgins, M., & Haber, M. (2012).
Rural African American parents’ knowledge and decisions about human
papillomavirus vaccination. Journal of Nursing Scholarship, 44(4), 358-367. doi:
10.1111/j.1547-5069.2012.01479.x
Thomas, T. L., Strickland, O. L., & Higgins, M. (2017). Mothers, Fathers, Sons, and
Human Papillomavirus Immunization Practices. Family & Community Health,
40(3), 278-287. doi: 10.1097/FCH.0000000000000104.
Thomas, T. L., Yarandi, H. N., Dalmida, S. G., Frados, A., & Klienert, K. (2015). Crosscultural differences and sexual risk behavior of emerging adults. Journal of
Transcultural Nursing, 26(1), 64-72. doi: 10.1177/1043659614524791
Thomas, T. L., Caldera, M., & Maurer, J. (2019). A short report: Parents HPV vaccine
knowledge in rural South Florida. Human Vaccines &Iimmunotherapeutics, 15(78), 1666-1671.
Thompson, V. L. S., Butler-Barnes, S. T., Jones, B. D., Wells, A. A., CunninghamWilliams, R. M., & Williams, S. L. (2017). Factors associated with human
papillomavirus vaccination status at US Colleges and Universities. Health &
Social Work, 42(1), e1-e7. doi: 10.1093/hsw/hlw050
Turchik, J. A., & Garske, J. P. (2009). Measurement of sexual risk among college
students. Archives of Sexual Behavior, 38(6), 936-948. doi: 10.1007/s10508-008-9388-z

125

Turchik, J. A., Walsh, K. & Marcus, D. K. (2015). Confirmatory validation of the factor
structure and reliability of the sexual risk survey in a large multiuniversity same
of U. S. students. International Journal of Sexual Health, 27(2), 93-105. doi:
10.1080/19317611.2014.944295.
Vanderpool, R. C., Stradtman, L. R., & Brandt, H. M. (2019). Policy opportunities to
increase HPV vaccination in rural communities. Human vaccines &
Immunotherapeutics, 15(7-8), 1527-1532.
US Census Bureau (USCB). 2010. Census Summary File 1. Retrieved from
Factfinder.census.gov.
US Census Bureau (USCB). 2012. U.S. Interim Projection by Age, Sex, Race, and
Hispanic Origin: 2000-2050, detailed data files. Retrieved from
http://www.census.gov/ic/www/usinterimproj/
United States Department of Commerce (USDA). (n.d.). Quick facts United States.
Retrieved from https://www.census.gov/quickfacts/table/PST045216/00
US Department Healthy People (USDHP). (2013b). IID-11.4 Increase the vaccination
coverage level of 3 doses of human papillomavirus (HPV) vaccine for females by
age 13 to 15 years. Retrieved from
http://www.healthypeople.gov/2020/Data/SearchResult.aspx?topicid=23&topic=I
mmunization and Infectious Diseases&objective=IID-11.4&anchor=567809
U.S. Department of Health and Human Services (USDHHS). (2018a). FDA approves
expanded use of Gardasil 9 to include individuals 27 through 45 years old.
Retrieved from
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622715.h
tm
US Department Healthy and Human Services (USDHHS). (2018b). Immunizations and
infectious diseases. Retrieved from https://www.healthypeople.gov/2020/topicsobjectives/topic/immunization-and-infectious-diseases/objectives
US Food and Drug Administration (FDA). (2013). FDA approves new indication for
gardasil to prevent genital warts in men and boys. Retrieved from:
http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm187003.htm
US Food and Drug Administration (FDA). (2014). Gardasil (Human Papillomavirus
Vaccine) questions and answers - Gardasil, June 8, 2006. Retrieved from:
http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/uc
m096052.htm

126

Vamos, C. A., McDermott, R. J., & Daley, E. M. (2008). The HPV vaccine: framing the
arguments for and against mandatory vaccination of all middle school girls. The
Journal of School Health, 78(6), 302-309. doi: 10.1111/j.17461561.2008.00306.x.
Walker, T. Y., Elam-Evans, L. D., Singleton, J. A. Yankey, D., Markowitz, L. E., Fredua,
B., Williams, C. L., Meyer, S. A., & Stokley, S. (2016). National, regional, state,
and selected local area vaccination coverage among adolescents aged 13–17 years
— United States, 2016. Morbidity and Mortality Weekly Report, 66(33), 874-882.
doi: http://dx.doi.org/10.15585/mmwr.mm6633a2
Watson, M., Saraiya, M., Benard, V., Coughlin, S. S., Flowers, L., Cokkinides, V.,
Schewenn, M., Huang, Y. & Giuliano, A. (2008). Burden of cervical cancer in the
United States, 1998-2003. Cancer, 113(10 Suppl), 2855-2864. doi:
10.1002/cncr.23756.
White, M. D. (2014). Pros, cons, and ethics of HPV vaccine in teens—Why such
controversy? Translational andrology and urology, 3(4), 429. doi:
10.3978/j.issn.2223-4683.2014.11.02
White House Initiative on Historically Black Colleges and Universities (US). (2013).
White house initiative on historically Black college and universities. Ann Arbor,
MI. Retrieved from US Department of Education http://www.ed.gov.
Widdice, L. E. & Moscicki, A. B., (2008). Updated guidelines for papanicolaou tests,
colposcopy, and human papillomavirus testing in adolescents. Journal of
Adolescent Health, 43(4), S41-S51. doi: 10.1016/j.jadohealth.2008.04.007
Widdice, L. E., Bernstein, D. I., Leonard, A. C., Marsolo, K. A., & Kahn, J. A. (2011).
Adherence to the HPV vaccine dosing intervals and factors associated with
completion of 3 doses. Pediatrics 127(1), 77-84. doi: 10.1542/peds.2010-0812
Wilson, K. L., Smith, M. L., Rosen, B. L., Pulczinski, J. C., & Ory, M. G. (2017). HPV
vaccination status and mandate support for school-aged adolescents among
college females: a descriptive study. The Journal of School Nursing, 33(3), 232245. doi: 10.1177/1059840516659764
Wolwa, M., Blavo, C., Shah, R., Fleisher, J. M., & Espinal, T. (2013). Cervical cancer
knowledge and prevention among college women. Journal of Community Health,
38(6), 997-1002. doi: 10.1007/s10900-013-9707-8
World Health Organization. (WHO). (2016). Sexual and World Health Organization
Reproductive Health. Retrieved from
http://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/

127

Younge, S. N., Corneille, M. A., Lyde, M., & Cannady, J. (2013). The paradox of risk:
Historically black college/ university students and sexual health. Journal of
American College Health, 61(5), 254–262.
Zimet G. D. (2006). Understanding and overcoming barriers to human papillomavirus
vaccine acceptance. Current Opinion in Obstetrics and Gynecology, 18, 23-28.

128

VITA
KAYLA MATHIS-GAMBLE, PhD (c), MSN, APRN-BC

1995-1999

BSN, Nursing
Tuskegee University
Tuskegee, Alabama

2006-2008

MSN, Nursing
Florida International University
Miami, Florida

2016-2020

Doctoral Candidate
Florida International University
Miami, Florida

1999-2003

Registered Nurse
North Broward Hospital District

2002-2008

Teacher
School Board of Broward County

2008-present

Assistant Professor
Broward College

Nurses Charitable Trust 2019 $500 research grant recipient; Principal Investigator
PUBLICATIONS AND PRESENTATIONS
Jones, S. G., Mathis-Gamble, K., & Fenkl, E. (2017). Minority college student’ HPV
knowledge, awareness, and vaccine history. Journal of Nurses in AIDS Care, accepted
April 2017
Mathis-Gamble, K., Santana, J. C., Teeson, K., Stanley, L., & Thomas, T. (2008). A pilot
study to test the Spanish version of the Thomas HPV Survey to Measure Parents’
Knowledge, Attitudes, Beliefs, and Intent to Vaccinate with the New HPV Vaccine.
Poster presented at the 2008 Southern Nurses Research Society, Birmingham, AL.
Mathis-Gamble, K., Jones, S.G., & Fenkl, E., Poster: Minority College Students’ HPV
Knowledge, Awareness, and Vaccination History. Poster Discussion Presentation, 29th
Annual Conference, Sigma Theta Tau International 27th International Nursing Research
Congress, Cape Town, South Africa, July 21-25 2016

129

Mathis-Gamble, K., Jones, S.G., Strickland, O., Fenkl, E., & Kameka, M. Poster: HPV
Vaccination Intentions in Black Young Adults: Preliminary Data. Poster Discussion
Presentation, 29th Annual Conference, Sigma Theta Tau International 30th International
Nursing Research Congress, Calgary, Canada, July 25-29 2019
Mathis-Gamble, K., Santana, J. C., Teeson, K., Stanley, L., & Thomas, T. (2008). A pilot
study to test the Spanish version of the Thomas HPV Survey to Measure Parents’
Knowledge, Attitudes, Beliefs, and Intent to Vaccinate with the New HPV Vaccine.
Poster presented at the 2008 Southern Nurses Research Society, Birmingham, AL.
Mathis-Gamble, K., Jones, S.G., & Fenkl, E., (2015). Poster: Minority College Students’
HPV Knowledge, Awareness, and Vaccination History. Podium/Poster Discussion
Presentation, 29th Annual Conference, Southern Nursing Research Society, Tampa, FL.,
February 26-28, 2015
1st place in the Minority Health Research Student category, Mathis-Gamble, K., Jones,
S.G., & Fenkl, E., (2015). Poster: Minority College Students’ HPV Knowledge,
Awareness, and Vaccination History. Podium/Poster Discussion Presentation, 29th
Annual Conference, Southern Nursing Research Society, Tampa, FL., February 26-28,
2015

130

